<SEC-DOCUMENT>0001213900-25-058389.txt : 20250626
<SEC-HEADER>0001213900-25-058389.hdr.sgml : 20250626
<ACCEPTANCE-DATETIME>20250626160514
ACCESSION NUMBER:		0001213900-25-058389
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		9
CONFORMED PERIOD OF REPORT:	20250626
FILED AS OF DATE:		20250626
DATE AS OF CHANGE:		20250626

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allot Ltd.
		CENTRAL INDEX KEY:			0001365767
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		ORGANIZATION NAME:           	06 Technology
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33129
		FILM NUMBER:		251080382

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		22 HANGAR STREET
		STREET 2:		NEVE NE'EMAN, INDUSTRIAL ZONE B
		CITY:			HOD-HASHARON
		NON US STATE TERRITORY:  	ISRAEL
		PROVINCE COUNTRY:   	L3
		ZIP:			4501317
		BUSINESS PHONE:		972-9-761-9200

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		22 HANGAR STREET
		STREET 2:		NEVE NE'EMAN, INDUSTRIAL ZONE B
		CITY:			HOD-HASHARON
		NON US STATE TERRITORY:  	ISRAEL
		PROVINCE COUNTRY:   	L3
		ZIP:			4501317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Allot Communications Ltd.
		DATE OF NAME CHANGE:	20060612
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0247086-6k_allot.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13a-16</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT
OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of June 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission file number: 001-33129</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Allot Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>22 Hanagar Street</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Neve Ne&rsquo;eman Industrial Zone B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hod-Hasharon 45240</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Israel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F &#9746; Form 40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Offering and Underwriting Agreement </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 24, 2025, Allot Ltd. (the &ldquo;Company&rdquo;) entered into
an underwriting agreement (the &ldquo;Underwriting Agreement&rdquo;) with TD Securities (USA) LLC and William Blair &amp; Company, L.L.C.,
as representatives of the several underwriters named therein (collectively, the &ldquo;Underwriters&rdquo;), in connection with the issuance
and sale by the Company of 5,000,000 ordinary shares, par value NIS 0.10 per share (the &ldquo;Ordinary Shares&rdquo;), at a price to
the public of $8.00 per Ordinary Share, for gross proceeds, before deducting underwriting discount and commissions and offering expenses,
of $40.0 million (the &ldquo;Offering&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Underwriting Agreement, the Company
granted the Underwriters a 30-day option to purchase up to an additional 750,000 Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All Ordinary Shares sold in the Offering were
offered by the Company and are listed for trading on the Nasdaq Global Select Market. The Offering closed on June 26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Underwriting Agreement contains customary
representations, warranties and agreements by the Company, customary conditions to closing, indemnification and contribution obligations
of the Company and the Underwriters including for certain liabilities under the Securities Act of 1933, as amended, and other obligations
of the parties, and termination provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description is not complete and
does not purport to be a complete description of the rights and obligations of the parties thereunder, and is qualified in its entirety
by reference to the Underwriting Agreement that is filed as Exhibit 1.1 to this Report on Form 6-K (the &ldquo;Report&rdquo;) and is incorporated
by reference herein.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Offering was made pursuant to the Company&rsquo;s
registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891325001089/zk2532909.htm">Form F-3</A> (File No. 333-286174), which was filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
on March 27, 2025 and declared effective on April 3, 2025 (the &ldquo;Registration Statement&rdquo;), a prospectus, dated April 3, 2025
included as part of the Registration Statement, a preliminary prospectus supplement, dated June 24, 2025 and filed with the SEC on June
24, 2025, and a final prospectus supplement, dated June 24, 2025 and filed with the SEC on June 25, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The attached opinion of Goldfarb Gross Seligman&nbsp;&amp; Co. regarding certain Israeli law matters relating to the Offering, including the validity of the Ordinary Shares sold in the Offering,
is hereby incorporated by reference into the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Lynrock Note</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 24, 2025, the Company entered into an
amendment (the &ldquo;Amendment&rdquo;) to its existing senior unsecured convertible promissory note with a face value of $40.0 million
issued by the Company to Lynrock Lake Master Fund LP, a major shareholder of the Company (&ldquo;Lynrock&rdquo;), on February 18, 2022
(as amended, the &ldquo;Lynrock Note&rdquo;). Pursuant to the Amendment, which was conditional upon the closing of the Offering, $31.41
million of the outstanding principal amount under the Note was to be repaid and cancelled in exchange for consideration consisting of
$31.41 million in cash from the net proceeds of the Offering, and the remaining $8.59 million principal amount outstanding under the Lynrock
Note was to be converted into Ordinary Shares at a conversion rate per $1,000 principal amount equal to $1,164.14 divided by the lower
of (x) $9.296 and (y) the public offering price, concurrent with the closing of the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 26, 2025, concurrent with the closing of the
Offering, the Company repaid $31.41 million of principal under the Lynrock Note from the proceeds of the Offering and is converting the
remaining $8.59 million of principal under the Lynrock Note into 1,249,995 Ordinary Shares, reflecting a conversion rate per $1,000 principal
amount equal to $1,164.14 divided by the public offering price. As a result of the repayment and conversion and following the completion
of the Offering, the Lynrock Note will be cancelled and, upon delivery of the Ordinary Shares, Lynrock will own approximately 21.8% of
the outstanding Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description is not complete and
does not purport to be a complete description of the rights and obligations of the parties thereunder, and is qualified in its entirety
by reference to the Amendment that is filed as Exhibit 10.1 to this Report and is incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained herein, including the
Underwriting Agreement attached hereto as Exhibit 1.1 and the Amendment attached hereto as Exhibit 10.1, is hereby incorporated by reference
into (i) the Registration Statement and (ii) the Company&rsquo;s Registration Statements on <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891322001467/zk2227600.htm">Form F-3</A> (File No. 333-264202 filed with the
SEC on April 8, 2022 and Form S-8 (File Nos. <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891307000305/zk73400.htm">333-140701</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000114420408009201/v103758_s-8.htm">333-149237</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891309001200/zk96786.htm">333-159306</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891310000616/zk1007994.htm">333-165144</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891311000612/zk1109525.htm">333-172492</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891312001116/zk1211336.htm">333-180770</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891313000843/zk1312827.htm">333-187406</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891314001090/zk1414658.htm">333-194833</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891315001063/zk1516503.htm">333-203028</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891316004875/zk1618267.htm">333-210420</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891317000867/zk1719713.htm">333-216893</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891318000918/zk1821387.htm">333-223838</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891319000877/zk1922833.htm">333-230391</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891320000945/zk2024206.htm">333-237405</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891321001041/zk2125757.htm">333-254298</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891322001212/zk2227509.htm">333-263767</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891323001147/zk2329435.htm">333-270903</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891324001299/zk2431203.htm">333-278607</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1365767/000117891325000629/zk2532776.htm">333-285268</A>)
filed with the SEC on February 14, 2007, February 14, 2008, May 18, 2009, March 2, 2010, February 28, 2011, April 17, 2012, March 21,
2013, March 27, 2014, March 26, 2015, March 28, 2016, March 23, 2017, March 22, 2018, March 19, 2019, March 26, 2020, March 15, 2021,
March 22, 2022, March 28, 2023, April 10, 2024 and February 26, 2025, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Press Releases</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 24, 2025, the Company issued a press release
announcing the launch of the Offering, which is attached hereto as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 24, 2025, the Company issued a press release
announcing the pricing of the Offering, which is attached hereto as Exhibit 99.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Allot Ltd.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap"><FONT STYLE="font-size: 10pt">/s/ Liat Nahum</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-size: 10pt">Liat Nahum</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: June 26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT INDEX</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 9%"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 90%"><FONT STYLE="font-size: 10pt"><B>Document Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">1.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea024708601ex1-1_allot.htm"><FONT STYLE="font-size: 10pt">Underwriting Agreement, dated June 24, 2025.</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">5.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea024708601ex5-1_allot.htm"><FONT STYLE="font-size: 10pt">Opinion of Goldfarb Gross Seligman &amp; Co.</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea024708601ex10-1_allot.htm"><FONT STYLE="font-size: 10pt">Amendment to Convertible Promissory Note, dated June 24, 2025.</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="ea024708601ex99-1_allot.htm"><FONT STYLE="font-size: 10pt">Allot Launch Press Release, dated June 24, 2025</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">99.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea024708601ex99-2_allot.htm"><FONT STYLE="font-size: 10pt">Allot Pricing Press Release, dated June 24, 2025</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea024708601ex1-1_allot.htm
<DESCRIPTION>UNDERWRITING AGREEMENT, DATED JUNE 24, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ALLOT LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>UNDERWRITING AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">June 24, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">TD Securities
(USA) LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">William
Blair &amp; Company, L.L.C.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-align: justify">As Representatives of the several Underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o TD Securities (USA) LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1 Vanderbilt Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o William Blair &amp; Company, L.L.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">150 N. Riverside Plaza</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chicago, Illinois 60606</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Sirs and Madams:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>1. <FONT STYLE="font-variant: small-caps">Introductory</FONT></I>.
Allot Ltd., a company organized under the laws of the State of Israel (the &ldquo;<B><I>Company</I></B>&rdquo;), proposes to sell,
pursuant to the terms of this Agreement, to the several underwriters named in <U>Schedule A</U> hereto (the
&ldquo;<B><I>Underwriters</I></B>,&rdquo; or, each, an &ldquo;<B><I>Underwriter</I></B>&rdquo;), an aggregate of 5,000,000 of the
Company&rsquo;s ordinary shares, par value NIS 0.10 per share (the &ldquo;<B><I>Ordinary Shares</I></B>&rdquo;). The aggregate of
5,000,000 Ordinary Shares so proposed to be sold is hereinafter referred to as the &ldquo;<B><I>Firm Shares</I></B>&rdquo;. The
Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 3 hereof, up to an additional
750,000 Ordinary Shares (the &ldquo;<B><I>Optional Shares</I></B>&rdquo;). The Firm Shares and the Optional Shares are hereinafter
collectively referred to as the &ldquo;<B><I>Shares</I></B>&rdquo;. TD Securities (USA) LLC and William Blair &amp; Company, L.L.C.
are acting as representatives of the several Underwriters and in such capacity are hereinafter referred to as the
&ldquo;<B><I>Representatives</I></B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-variant: small-caps; text-transform: uppercase"><I>2. </I></FONT><I><FONT STYLE="font-variant: small-caps">Representations
and Warranties of the Company. </FONT></I>The Company represents and warrants to the several Underwriters, as of the date hereof and as
of each Closing Date (as defined below), and agrees with the several Underwriters, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-variant: small-caps; text-transform: uppercase"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-variant: small-caps">(a) </FONT><U>Shelf
Registration Statement</U>. A registration statement of the Company on Form F-3 (File No. 333-286174) (including all amendments
thereto, the &ldquo;<B><I>Initial Registration Statement</I></B>&rdquo;) in respect of the Shares has been filed with the Securities
and Exchange Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;) pursuant to Rule 415 under the Securities Act of 1933, as
amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;). The Company meets the requirements for use of Form F-3 under the
Securities Act, and the rules and regulations of the Commission thereunder (the &ldquo;<B><I>Rules and Regulations</I></B>&rdquo;).
The Initial Registration Statement and any post-effective amendment thereto, each in the form heretofore delivered to you, and,
excluding exhibits thereto, to you for each of the other Underwriters, have been declared effective by the Commission in such form
and meet the requirements of the Securities Act, and the Rules and Regulations. The proposed offering of the Shares may be made
pursuant to General Instruction I.B.1 of Form F-3. Other than (i) the Initial Registration Statement, (ii) a registration statement,
if any, increasing the size of the offering filed pursuant to Rule 462(b) under the Securities Act and the Rules and Regulations (a
&ldquo;<B><I>Rule 462(b) Registration Statement</I></B>&rdquo;), (iii) any Preliminary Prospectus (as defined below), (iv) the
Prospectus (as defined below) contemplated by this Agreement to be filed pursuant to Rule 424(b) of the Rules and Regulations in
accordance with Section 4(a) hereof and (v) any Issuer Free Writing Prospectus (as defined below), no other document with respect to
the offer or sale of the Shares has heretofore been filed with the Commission. No stop order suspending the effectiveness of the
Initial Registration Statement, any post-effective amendment thereto or the Rule 462(b) Registration Statement has been issued and
no proceeding for that purpose or pursuant to Section 8A of the Securities Act has been initiated or threatened by the Commission
(any preliminary prospectus included in the Initial Registration Statement or filed with the Commission pursuant to Rule 424 of the
Rules and Regulations is hereinafter called a &ldquo;<B><I>Preliminary Prospectus</I></B>&rdquo;). The Initial Registration
Statement including all exhibits thereto and including the information contained in the Prospectus filed with the Commission
pursuant to Rule 424(b) of the Rules and Regulations and deemed by virtue of Rule 430B under the Securities Act to be part of the
Initial Registration Statement at the time it became effective is hereinafter collectively called the &ldquo;<B><I>Registration
Statement</I></B>.&rdquo; If the Company has filed a Rule 462(b) Registration Statement, then any reference herein to the term
&ldquo;Registration Statement&rdquo; shall be deemed to include such Rule 462(b) Registration Statement. The base prospectus
included in the Initial Registration Statement at the time of effectiveness thereof (the &ldquo;<B><I>Base
Prospectus</I></B>&rdquo;), as supplemented by the final prospectus supplement relating to the offer and sale of the Shares, in the
form filed pursuant to and within the time limits described in Rule 424(b) under the Rules and Regulations, including any document
incorporated by reference therein, is hereinafter called the &ldquo;<B><I>Prospectus</I></B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-variant: small-caps; text-transform: uppercase"><I>&nbsp;</I></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-variant: small-caps; text-transform: uppercase"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Any reference herein to the Registration
Statement, Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein.
Any reference to any amendment or supplement to any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any
documents filed after the date of such Preliminary Prospectus or the Prospectus under the Securities Exchange Act of 1934, as amended
(the &ldquo;<B><I>Exchange Act</I></B>&rdquo;), and incorporated by reference in such Preliminary Prospectus or Prospectus, as the case
may be. Any reference to any amendment to the Registration Statement shall be deemed to refer to and include any annual report of the
Company filed pursuant to Section 13(a) or 15(d) of the Exchange Act after the date of this Agreement that is incorporated by reference
in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(b) <FONT STYLE="font-size: 10pt"><U>General
Disclosure Package</U>. As of the Applicable Time (as defined below) and as of the Closing Date or the Option Closing Date (as defined
below), as the case may be, neither (i) the General Use Free Writing Prospectus(es) (as defined below) issued at or prior to the Applicable
Time, the Pricing Prospectus (as defined below) and the information included on <U>Schedule C</U> hereto, all considered together (collectively,
the &ldquo;<B><I>General Disclosure Package</I></B>&rdquo;), nor (ii) any individual Limited Use Free Writing Prospectus (as defined below),
nor (iii) the bona fide electronic roadshow (as defined in Rule 433(h)(5) of the Rules and Regulations), when considered together with
the General Disclosure Package, included or will include any untrue statement of a material fact or omitted or will omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
<I>provided, however</I>, that the Company makes no representations or warranties as to information contained in or omitted from the Pricing
Prospectus or any Issuer Free Writing Prospectus (as defined below), in reliance upon, and in conformity with, written information furnished
to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information the
parties hereto agree is limited to the Underwriters&rsquo; Information (as defined in Section 19). As used in this paragraph (b) and elsewhere
in this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Applicable Time</I></B>&rdquo;
means 7:00 P.M., New York time, on the date of this Agreement or such other time as agreed to by the Company and the Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Pricing Prospectus</I></B>&rdquo;
means the Base Prospectus, as amended and supplemented immediately prior to the Applicable Time, including any document incorporated by
reference therein and any prospectus supplement deemed to be a part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Issuer Free Writing
Prospectus</I></B>&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the Rules and Regulations
relating to the Shares in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained
in the Company&rsquo;s records pursuant to Rule 433(g) of the Rules and Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>General Use Free
Writing Prospectus</I></B>&rdquo; means any Issuer Free Writing Prospectus that is identified on <U>Schedule B</U> to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Limited Use Free
Writing Prospectuses</I></B>&rdquo; means any Issuer Free Writing Prospectus that is not a General Use Free Writing Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(c) <FONT STYLE="font-size: 10pt"><U>No
Stop Orders; No Material Misstatements</U>. No order preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing
Prospectus or the Prospectus relating to the proposed offering of the Shares has been issued by the Commission, and no proceeding for
that purpose or pursuant to Section 8A of the Securities Act has been instituted or threatened by the Commission, and each Preliminary
Prospectus, at the time of filing thereof, conformed in all material respects to the requirements of the Securities Act and the Rules
and Regulations, and did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided,
however</I>, that the Company makes no representations or warranties as to information contained in or omitted from any Preliminary Prospectus,
in reliance upon, and in conformity with, written information furnished to the Company through the Representatives by or on behalf of
any Underwriter specifically for inclusion therein, which information the parties hereto agree is limited to the Underwriters&rsquo; Information.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(d) <U>Registration Statement
and Prospectus Contents</U>. At the respective times, the Registration Statement and any amendments thereto became or become effective
as to the Underwriters and at each Closing Date, the Registration Statement and any amendments thereto conformed and will conform in
all material respects to the requirements of the Securities Act and the Rules and Regulations and did not and will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein
not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement
thereto was issued and at each Closing Date, conformed and will conform in all material respects to the requirements of the Securities
Act and the Rules and Regulations and did not and will not contain an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; <I>provided</I>,
<I>however</I>, that the foregoing representations and warranties in this paragraph (d) shall not apply to information contained in or
omitted from the Registration Statement or the Prospectus, or any amendment or supplement thereto, in reliance upon, and in conformity
with, written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion
therein, which information the parties hereto agree is limited to the Underwriters&rsquo; Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(e) <FONT STYLE="font-size: 10pt"><U>Issuer
Free Writing Prospectus</U>. Each Issuer Free Writing Prospectus, as of its issue date and at all subsequent times through the completion
of the public offer and sale of the Shares or until any earlier date that the Company notified or notifies the Representatives as described
in Section 4(e), did not, does not and will not include any information that conflicted, conflicts or will conflict with the information
contained in the Registration Statement, Pricing Prospectus or the Prospectus, including any document incorporated by reference therein
and any prospectus supplement deemed to be a part thereof that has not been superseded or modified, or included or would include an untrue
statement of a material fact or omitted or would omit to state a material fact required to be stated therein or necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading, <I>provided</I>, <I>however</I>,
that the foregoing representations and warranties in this paragraph (e) shall not apply to information contained in or omitted from the
Registration Statement or the Prospectus, or any amendment or supplement thereto, in reliance upon, and in conformity with, written information
furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information
the parties hereto agree is limited to the Underwriters&rsquo; Information. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(f) <FONT STYLE="font-size: 10pt"><U>Documents
Incorporated by Reference.</U> The documents incorporated by reference in the Prospectus, when they became effective or were filed with
the Commission, as the case may be, conformed in all material respects to the requirements of the Securities Act or the Exchange Act,
as applicable, and the rules and regulations of the Commission thereunder and none of such documents contained any untrue statement of
a material fact or omitted to state any material fact required to be stated therein, or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference
in the Prospectus, when such documents are filed with the Commission will conform in all material respects to the requirements of the
Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder and will not contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(g) <FONT STYLE="font-size: 10pt"><U>Foreign
Private Issuer</U>. The Company is a &ldquo;foreign private issuer&rdquo; within the meaning of Rule 405 of the Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(h) <FONT STYLE="font-size: 10pt"><U>Distribution
of Offering Materials</U>. The Company has not, directly or indirectly, distributed and will not distribute any offering material in connection
with the offering and sale of the Shares other than any Preliminary Prospectus, the Prospectus and other materials, if any, permitted
under the Securities Act. The Company will file with the Commission all Issuer Free Writing Prospectuses (other than a &ldquo;road show&rdquo;
as described in Rule 433(d)(8) of the Rules and Regulations) in the time and manner required under Rules 163(b)(2) and 433(d) of the Rules
and Regulations. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(i) <FONT STYLE="font-size: 10pt"><U>Not
an Ineligible Issuer</U>. At the time of filing the Initial Registration Statement, any Rule 462(b) Registration Statement and any post-effective
amendments thereto, and at the date hereof, the Company was not, and the Company currently is not, an &ldquo;ineligible issuer,&rdquo;
as defined in Rule 405 of the Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(j) <FONT STYLE="font-size: 10pt"><U>Organization
and Good Standing</U>. The Company and each of its subsidiaries (as defined in Section 16) have been duly organized and are validly existing
as corporations or other legal entities in good standing (to the extent such concept exists) under the laws of their respective jurisdictions
of organization. The Company and each of its subsidiaries are duly qualified to do business and are in good standing as foreign corporations
or other legal entities in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective
businesses requires such qualification and have all power and authority (corporate or other) necessary to own or hold their respective
properties and to conduct the businesses in which they are engaged, except where the failure to so qualify or have such power or authority
would not (i) have, singularly or in the aggregate, a material adverse effect on the business, properties, management, financial position,
shareholders&rsquo; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole, or (ii) impair in
any material respect the ability of the Company to perform its obligations under this Agreement or to consummate any transactions contemplated
by this Agreement, the General Disclosure Package or the Prospectus (any such effect as described in clauses (i) or (ii), a &ldquo;<B><I>Material
Adverse Effect</I></B>&rdquo;). The Company is not currently designated as a &ldquo;breaching company&rdquo; (within the meaning of the
Israeli Companies Law, 5759-1999, as amended (the &ldquo;<B><I>Companies Law</I></B>&rdquo;)) by the Registrar of the Companies of the
State of Israel, and, to the Company&rsquo;s Knowledge, there is no basis for such designation. The memorandum of association, articles
of association, certificate of incorporation and by-laws (and other applicable organizational documents) of the Company and each of its
subsidiaries comply with the requirements of applicable law in its jurisdiction of incorporation and are in full force and effect. The
Company does not own or control, directly or indirectly, any corporation, association or other entity other than (A) the subsidiaries
listed on Exhibit 8.1 to the Company&rsquo;s Annual Report on Form 20-F incorporated by reference in the Registration Statement,</FONT>
and (B) <FONT STYLE="font-size: 10pt">certain other subsidiaries which, considered in the aggregate as a single subsidiary, do not constitute
a &ldquo;significant subsidiary&rdquo; as defined in Rule 1-02(w) of Regulation S-X. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(k) <FONT STYLE="font-size: 10pt"><U>Underwriting
Agreement</U>. This Agreement has been duly authorized (including, to the extent applicable, under Chapter 5 of Part VI of the Companies
Law), executed and delivered by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(l) <FONT STYLE="font-size: 10pt"><U>The
Shares</U>. The Shares to be issued and sold by the Company to the Underwriters hereunder have been duly and validly authorized and, when
issued and delivered against payment therefor as provided herein, will be duly and validly issued, fully paid and non-assessable and will
conform to the descriptions thereof in the Registration Statement, the General Disclosure Package and the Prospectus; and the issuance
of the Shares is not subject to any preemptive or similar rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(m) <FONT STYLE="font-size: 10pt"><U>Capitalization</U>.
The authorized, issued and outstanding Ordinary Shares of the Company are as set forth or incorporated by reference in the Registration
Statement, the General Disclosure Package and the Prospectus in the column titled &ldquo;Actual&rdquo; under the caption &ldquo;<I>Capitalization</I>&rdquo;
(except for subsequent issuances, if any, (A) pursuant to this Agreement, (B) pursuant to reservations, agreements or employee benefit
or equity incentive plans referred to in the Registration Statement, the General Disclosure Package and the Prospectus or (C) pursuant
to the exercise of convertible securities or options referred to in the Registration Statement, the General Disclosure Package and the
Prospectus). The outstanding Ordinary Shares of the Company have been duly authorized and validly issued and are fully paid and non-assessable,
and conform in all material respects to the description thereof contained in the Prospectus and were issued in compliance with the Companies
Law, the Israeli Securities Law, 5728-1968 (the &ldquo;<B><I>Israeli Securities Law</I></B>&rdquo;), and U.S. securities laws, as applicable,
and were not issued in violation of any preemptive right, resale right, right of first refusal or similar right. Except as described in
the Prospectus, there are no outstanding convertible debt securities, options, warrants or other rights to purchase or exchange any securities
for any share capital or other equity interest in the Company or any of its &ldquo;significant subsidiaries&rdquo; within the meaning
of Rule 1-02(w) of Regulation S-X. All of the Company&rsquo;s convertible debt securities, options, warrants and other rights to purchase
or exchange any securities for any share capital or other equity interest in the Company have been duly authorized and validly issued,
conform in all material respects to the description thereof contained in the Prospectus and were issued in compliance with applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(n) <FONT STYLE="font-size: 10pt"><U>Capitalization
of Subsidiaries</U>. All of the outstanding share capital of each subsidiary of the Company has been duly authorized and validly issued,
is fully paid and nonassessable and, except to the extent set forth in the General Disclosure Package or the Prospectus, is owned by the
Company directly or indirectly through one or more wholly-owned subsidiaries, free and clear of any claim, lien, encumbrance, security
interest, restriction upon voting or transfer or any other claim of any third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(o) <FONT STYLE="font-size: 10pt"><U>Share
Options</U>. Except as described in the Registration Statement, in the General Disclosure Package and in the Prospectus, there are no
options, warrants, agreements, contracts or other rights in existence to purchase or acquire from the Company or any subsidiary of the
Company, any Ordinary Shares of the Company or any shares of any subsidiary of the Company. The description of the Company&rsquo;s share
option, warrants, share bonus and other share plans or arrangements (the &ldquo;<B><I>Company Share Plans</I></B>&rdquo;), and the options,
warrants and other equity awards or rights to acquire Ordinary Shares (together, the &ldquo;<B><I>Options</I></B>&rdquo;) or other rights
granted thereunder, set forth in the General Disclosure Package and the Prospectus accurately and fairly presents the information required
to be shown with respect to such plans, arrangements, options, warrants and rights. Each (A) grant of an Option was duly authorized no
later than the date on which the grant of such Option was by its terms to be effective by all necessary corporate action, including, as
applicable, approval by the board of directors of the Company (and/or a duly constituted and authorized committee thereof) and any required
shareholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly
executed and delivered by each party thereto, (B) grant of an Option was made in accordance with the terms of the applicable Company Share
Plan, and all applicable laws and regulatory rules or requirements, including all applicable United States federal securities laws, the
Israeli Securities Law and the rules of the Tel Aviv Stock Exchange (the &ldquo;<B><I>TASE</I></B>&rdquo;) and any other exchange on which
Company securities are traded, (C) each Option purported to be issued under Section 102 of the Israeli Income Tax Ordinance (New Version),
5721-1961 qualifies for treatment under that section and for treatment under either the capital gains track or the employment income track,
as was indicated with respect to each such Option at the date that such Option was granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(p) <FONT STYLE="font-size: 10pt"><U>No
Conflicts</U>. The execution, delivery and performance of this Agreement by the Company, the issue and sale of the Shares by the Company
and the consummation of the transactions contemplated hereby, including, without limitation, the proposed repayment in full and cancellation
of the senior secured convertible promissory note face value $40.0 million of the Company held by Lynrock Lake L.P. (as amended, the &ldquo;<B><I>Lynrock
Note</I></B>&rdquo;) in exchange for consideration consisting of $31.41 million in cash from the net proceeds of the offering and Ordinary
Shares of the Company to be issued based on the conversion rate set forth in the Lynrock Note, in a transaction exempt from registration
under the Securities Act closing concurrently with the offering to which this Underwriting Agreement relates, all as described under the
caption &ldquo;Use of Proceeds&rdquo; in the Preliminary Prospectus and General Disclosure Package, have been duly authorized by all necessary
corporate action, including, to the extent applicable, under Chapter 5 of Part VI of the Companies Law, and will not (with or without
notice or lapse of time or both) (i) conflict with or result in a breach or violation of any of the terms or provisions of, constitute
a default or a Debt Repayment Triggering Event (as defined below) under, or result in the creation or imposition of any lien, encumbrance,
security interest, claim or charge upon any property or assets of the Company or any of its subsidiaries pursuant to, any indenture, mortgage,
deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which
the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is
subject, (ii) result in any violation of the provisions of the memorandum of association, articles of association, charter or by-laws
(or analogous governing instruments, as applicable) of (A) the Company or (B) any of its subsidiaries or (iii) result in the violation
of any law, statute, rule, regulation, judgment, order or decree of any court or governmental or regulatory agency or body, domestic or
foreign (including Israel), having jurisdiction over the Company or any of its subsidiaries or any of their properties or assets, including,
without limitation, any instrument of approval granted by the Israel Innovation Authority, to which the Company or any of its subsidiaries
is a party or by which it or any of them may be bound or to which any of the properties or assets of the Company or any of its subsidiaries
is subject except, in the case of clauses (i), (ii)(B) and (iii) above, for any such conflict, breach, violation or default that would
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. A &ldquo;<B><I>Debt Repayment Triggering
Event</I></B>&rdquo; means any event or condition that gives, or with the giving of notice or lapse of time would give the holder of any
note, debenture or other evidence of indebtedness (or any person acting on such holder&rsquo;s behalf) the right to require the repurchase,
redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(q) <FONT STYLE="font-size: 10pt"><U>No
Consents Required</U>. Except for (A) the registration of the Shares under the Securities Act and applicable state securities laws, (B)
such consents, approvals, authorizations, orders and registrations or qualifications as may be required by the Financial Industry Regulatory
Authority (&ldquo;<B><I>FINRA</I></B>&rdquo;), the Nasdaq Global Select Market and the TASE in connection with the purchase and distribution
of the Shares by the Underwriters and the listing of the Shares on the Nasdaq Global Select Market and the TASE, and (C) filings with
the Israel Innovation Authority, no consent, approval, authorization or order of, or filing, qualification or registration (each an &ldquo;<B><I>Authorization</I></B>&rdquo;)
with, any court, governmental or regulatory agency or body, foreign (including Israeli) or domestic, which has not been made, obtained
or taken and is not in full force and effect, is required to be obtained by the Company for the execution, delivery and performance of
this Agreement, the issuance and sale of the Shares or the consummation by the Company of the transactions contemplated hereby; and no
event has occurred that allows or results in, or after notice or lapse of time or both would allow or result in, revocation, suspension,
termination or invalidation of any such Authorization or any other impairment of the rights of the holder or maker of any such Authorization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(r) <FONT STYLE="font-size: 10pt"><U>Independent
Auditors</U>. Kost Forer Gabbay &amp; Kasierer, a member of EY Global, who have certified certain financial statements and related schedules
of the Company and its subsidiaries included or incorporated by reference in the Registration Statement, the General Disclosure Package
and the Prospectus, and have audited the Company&rsquo;s internal control over financial reporting and management&rsquo;s assessment thereof,
is an independent registered public accounting firm with respect to the Company and its subsidiaries within the meaning of Article 2-01
of Regulation S-X and the Public Company Accounting Oversight Board (United States) (the &ldquo;<B><I>PCAOB</I></B>&rdquo;). </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(s) <FONT STYLE="font-size: 10pt"><U>Financial
Statements</U>. The financial statements, together with the related notes, included or incorporated by reference in the General Disclosure
Package, the Prospectus and in the Registration Statement fairly present the financial position and the results of operations and changes
in financial position of the Company and its consolidated subsidiaries at the respective dates or for the respective periods therein specified.
Such statements and related notes have been prepared in accordance with the generally accepted accounting principles in the United States
(&ldquo;<B><I>GAAP</I></B>&rdquo;) applied on a consistent basis throughout the periods involved except as may be set forth in the related
notes included or incorporated by reference in the General Disclosure Package. The financial statements, together with the related notes,
included or incorporated by reference in the General Disclosure Package and the Prospectus comply in all material respects with Regulation
S-X. No other financial statements or supporting schedules or exhibits are required by Regulation S-X to be described, included or incorporated
by reference in the Registration Statement, the General Disclosure Package or the Prospectus. There is no pro forma or as adjusted financial
information which is required to be included in the Registration Statement, the General Disclosure Package, and the Prospectus or a document
incorporated by reference therein in accordance with Regulation S-X which has not been included or incorporated as so required. The summary
and selected financial data included in the General Disclosure Package, the Prospectus and the Registration Statement fairly present the
information shown therein as at the respective dates and for the respective periods specified and are derived from the consolidated financial
statements set forth or incorporated by reference in the Registration Statement, the Pricing Prospectus and the Prospectus and other financial
information. All information contained in the Registration Statement, the General Disclosure Package and the Prospectus regarding &ldquo;non-GAAP
financial measures&rdquo; (as defined in Regulation G) complies with Regulation G and Item 10 of Regulations S-K, to the extent applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(t) <FONT STYLE="font-size: 10pt"><U>eXtensible
Business Reporting Language</U>. The interactive data in eXtensible Business Reporting Language included or incorporated by reference
in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance
with the Commission&rsquo;s rules and guidelines applicable thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(u) <FONT STYLE="font-size: 10pt"><U>No
Material Adverse Change</U>. Neither the Company nor any of its subsidiaries has sustained, since the date of the latest audited financial
statements included or incorporated by reference in the General Disclosure Package, (i) any material loss or interference with its business
from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or action, order or decree
of any court or governmental or regulatory authority, otherwise than as set forth in the General Disclosure Package; or (ii) any change
in the share capital (other than the issuance of Ordinary Shares upon exercise of share options and warrants or vesting of restricted
share units described as outstanding in, and the grant of options and awards under existing equity incentive plans described in, the Registration
Statement, the General Disclosure Package and the Prospectus) or long-term debt of the Company or any of its subsidiaries, or any dividend
or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of share capital, or any material
adverse changes, or any development involving a prospective material adverse change, in or affecting the business, properties, assets,
general affairs, management, financial position, prospects, shareholders&rsquo; equity or results of operations of the Company and its
subsidiaries taken as a whole, otherwise than as set forth or contemplated in the General Disclosure Package. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(v) <FONT STYLE="font-size: 10pt"><U>Legal
Proceedings</U>. Except as set forth in the General Disclosure Package, there is no legal or governmental proceeding pending to which
the Company or any of its subsidiaries is a party or of which any property or assets of the Company or any of its subsidiaries is the
subject that is required to be described in the Registration Statement, the General Disclosure Package or the Prospectus or a document
incorporated by reference therein and is not described therein, or which, singularly or in the aggregate, if determined adversely to the
Company or any of its subsidiaries, would reasonably be expected to have a Material Adverse Effect; and no such proceedings are threatened
or, to the Company&rsquo;s Knowledge after reasonable investigation and due diligence inquiry (&ldquo;<B><I>Knowledge</I></B>&rdquo;),
contemplated by governmental or regulatory authorities or threatened by others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(w) <FONT STYLE="font-size: 10pt"><U>No
Violation or Default</U>. Neither the Company nor any of its subsidiaries is (i) in violation of its memorandum of association, articles
of association, charter or by-laws (or analogous governing instrument, as applicable), (ii) in default, and no event has occurred which,
with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition
contained in any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a party or
by which it is bound or to which any of its property or assets is subject or (iii) in violation in any respect of any law, ordinance,
governmental rule, regulation or court order, decree or judgment to which it or its property or assets may be subject except, in the case
of clauses (i) (solely with respect to the Company&rsquo;s subsidiaries), (ii) and (iii) above, for any such violation or default that
would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(x) <U>Licenses
or Permits</U>. The Company and each of its subsidiaries holds, and is operating in compliance in all material respects with, all franchises,
grants, licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate
local, state, federal or foreign (including Israeli) governmental or regulatory agencies or bodies that are necessary for the ownership
or lease of their respective properties or the conduct of their respective businesses as described in the General Disclosure Package and
the Prospectus (collectively, the &ldquo;<B><I>Governmental Permits</I></B>&rdquo;) except where any failures to possess or make the same
would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries
are in compliance with all such Governmental Permits; all such Governmental Permits are valid and in full force and effect, except where
the validity or failure to be in full force and effect would not, singularly or in the aggregate, reasonably be expected to have a Material
Adverse Effect. Neither the Company nor any of its subsidiaries has received notification of any revocation, modification, suspension,
termination or invalidation (or proceedings related thereto) of any Governmental Permit and the Company has no reason to believe that
any such Governmental Permit will not be renewed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(y) <FONT STYLE="font-size: 10pt"><U>Investment
Company Act</U>. Neither the Company nor any of its subsidiaries is or, after giving effect to the offering of the Shares and the application
of the proceeds thereof as described in the General Disclosure Package and the Prospectus, will be, an &ldquo;investment company&rdquo;
within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(z) <FONT STYLE="font-size: 10pt"><U>No
Stabilization</U>. Neither the Company nor, to the Company&rsquo;s Knowledge, any of its officers, directors or affiliates has taken or
will take, directly or indirectly, any action designed or intended to stabilize or manipulate the price of any security of the Company,
or which caused or resulted in, or which might in the future reasonably be expected to cause or result in, stabilization or manipulation
of the price of any security of the Company. Neither the Company nor any of its subsidiaries have engaged, and neither the Company nor
any of its subsidiaries will engage, in any form of solicitation, advertising or other action constituting an offer or a sale to the public
under the Israeli Securities Law and the regulations promulgated thereunder in connection with the transactions contemplated hereby, which
would require the publication of a prospectus in the State of Israel under the laws of the State of Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(aa) <FONT STYLE="font-size: 10pt"><U>Intellectual
Property</U>. Except as would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect, the
Company and its subsidiaries own or possess the valid right to use all (i) valid and enforceable patents, patent applications,
trademarks, trademark registrations, service marks, service mark registrations, Internet domain name registrations, copyrights,
copyright registrations, licenses, trade secret rights (&ldquo;<B><I>Intellectual Property Rights</I></B>&rdquo;) and (ii)
inventions, software, works of authorships, trademarks, service marks, trade names, databases, formulae, know how, Internet domain
names and other intellectual property (including trade secrets and other unpatented and/or unpatentable proprietary confidential
information, systems, or procedures) (collectively, &ldquo;<B><I>Intellectual Property Assets</I></B>&rdquo;) used in or otherwise
necessary to conduct their respective businesses as currently conducted, and as proposed to be conducted and described in the
General Disclosure Package and the Prospectus. The Company and its subsidiaries have not received any opinion from their legal
counsel concluding that any activities of their respective businesses infringe, misappropriate, or otherwise violate, valid and
enforceable Intellectual Property Rights of any other person, and have not received written notice of any challenge, which is to
their Knowledge still pending, by any other person to the rights of the Company and its subsidiaries with respect to any
Intellectual Property Rights or Intellectual Property Assets owned or used by the Company or its subsidiaries. Except as would not,
singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect, (A) the Company and its
subsidiaries&rsquo; respective businesses as now conducted do not give rise to any infringement of, any misappropriation of, or
other violation of, any valid and enforceable Intellectual Property Rights of any other person, (B) all licenses for the use of the
Intellectual Property Rights described in the General Disclosure Package and the Prospectus are valid, binding upon, and enforceable
by or against the parties thereto in accordance with its terms, and (C) the Company and each of its subsidiaries has complied with,
and is not in breach nor has received any asserted or threatened claim of breach of any Intellectual Property license, and the
Company has no knowledge of any breach or anticipated breach by any other person to any Intellectual Property license. No claim has
been made against the Company or any of its subsidiaries alleging the infringement by the Company or any of its subsidiaries of any
patent, trademark, service mark, trade name, copyright, trade secret, license in or other intellectual property right or franchise
right of any person. The Company and each of its subsidiaries has taken all reasonable steps to protect, maintain and safeguard its
Intellectual Property Rights, including the execution of appropriate nondisclosure and confidentiality agreements. The consummation
of the transactions contemplated by this Agreement will not result in the loss or impairment of or payment of any additional amounts
with respect to, nor require the consent of any other person in respect of, the Company&rsquo;s or any of its subsidiaries&rsquo;
right to own, use, or hold for use any of the Intellectual Property Rights as owned, used or held for use in the conduct of the
business as currently conducted. With respect to the use of the software in the Company&rsquo;s or any of its subsidiaries&rsquo;
business as it is currently conducted, neither the Company nor any of its subsidiaries have experienced any material defects in such
software including any material error or omission in the processing of any transactions other than defects which have been
corrected. Except as would not reasonably be expected to have a Material Adverse Effect, (A) no government funding, facilities or
resources of a university, college, other educational institution or research center was used in the development of any Intellectual
Property Rights or Intellectual Property Assets, and no governmental agency or body (including the Israel Innovation Authority),
university, college, other educational institution or research center has any claim, option or right in or to any Intellectual
Property Rights or Intellectual Property Assets, and (B) the Company and its subsidiaries have taken commercially reasonable steps
to maintain the confidentiality of all trade secrets and other confidential information owned, used or held for use by the Company
or any of its subsidiaries. Except as would not reasonably be expected to have a Material Adverse Effect, the Company and its
subsidiaries, with respect to all software (including source code) and other materials that are distributed under a
&ldquo;free,&rdquo; &ldquo;open source,&rdquo; or similar licensing model (including the GNU General Public License, GNU Lesser
General Public License, GNU Affero General Public License, New BSD License, Apache License, Apache 2.0 License, MIT License, Common
Public License and other licenses approved as Open Source licenses under the Open Source Definition of the Open Source Initiative)
(&ldquo;<B><I>Open Source Materials</I></B>&rdquo;) are in compliance with all license terms applicable to such Open Source
Materials. To the Knowledge of the Company, except as would not reasonably be expected to have a Material Adverse Effect, neither
the Company nor any of its subsidiaries has used or distributed any Open Source Materials (or any software that links to Open Source
Materials) in a manner that requires or has required (A) the Company or any of its subsidiaries to permit reverse engineering of any
products or services of the Company or any of its subsidiaries, or any software code or other technology owned (or purported to be
owned) by the Company or any of its subsidiaries, or (B) any products or services of the Company or any of its subsidiaries, or any
software code or other technology owned (or purported to be owned) by the Company or any of its subsidiaries, to be (I) disclosed or
distributed in source code form or (II) redistributed at no charge or minimal charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(bb) <FONT STYLE="font-size: 10pt"><U>Privacy
Laws</U>. The Company and its subsidiaries are, and at all prior times were, in material compliance with all applicable data privacy
and security laws and regulations, including, without limitation, the Health Insurance Portability and Accountability Act
(&ldquo;<B><I>HIPAA</I></B>&rdquo;), as amended by the Health Information Technology for Economic and Clinical Health Act (the
&ldquo;<B><I>HITECH Act</I></B>&rdquo;) (42 U.S.C. Section 17921 et seq.), the Israeli Privacy Protection Law, 5741-1981, the
Israeli Privacy Protection Regulations (Data Security), 5777-2017, and the European Union General Data Protection Regulation
(&ldquo;<B><I>GDPR</I></B>&rdquo;) (EU 2016/679) (collectively, the &ldquo;<B><I>Privacy Laws</I></B>&rdquo;). To ensure compliance
with the Privacy Laws, the Company and its subsidiaries have in place, comply with, and take appropriate steps reasonably designed
to ensure compliance in all material respects with their policies and procedures relating to data privacy and security and the
collection, storage, use, disclosure, handling and analysis of Personal Data (the &ldquo;<B><I>Policies</I></B>&rdquo;).
&ldquo;<B><I>Personal Data</I></B>&rdquo; means (i) a natural persons&rsquo; name, street address, telephone number, email address,
photograph, social security or similar number, bank information, or customer or account number; (ii) any information which would
qualify as &ldquo;personally identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii) Protected
Health Information as defined by HIPAA; (iv) &ldquo;personal data&rdquo; as defined by GDPR; and (v) any other piece of information
that allows the identification of such natural person, or his or her family, or permits the collection or analysis of any data
related to an identified person&rsquo;s health or sexual orientation. None of such disclosures made or contained in any of the
Policies have been inaccurate, misleading, deceptive or in violation of any Privacy Laws or Policies in any material respect. The
execution, delivery and performance of this Agreement or any other agreement referred to in this Agreement will not result in a
breach of any Privacy Laws or Policies. Neither the Company nor any of its subsidiaries (i) has received notice of any actual or
potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any
event or condition that would reasonably be expected to result in any such notice; (ii) is currently conducting or paying for, in
whole or in part, any investigation, remediation or other corrective action pursuant to any Privacy Law; or (iii) is a party to any
order, decree, or agreement that imposed any obligation or liability under any Privacy Law. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(cc) <FONT STYLE="font-size: 10pt"><U>IT
Systems</U>. (i) (x) There has been no security breach or attack or other compromise of or relating to any of the Company&rsquo;s
and its subsidiaries&rsquo; information technology and computer systems, networks, hardware, software, data (including the data of
their respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of them), equipment or
technology (&ldquo;<B><I>IT Systems and Data</I></B>&rdquo;), and (y) the Company and its subsidiaries have not been notified of,
and have no knowledge of any event or condition that would reasonably be expected to result in any security breach, attack or
compromise to their IT Systems and Data, and (ii) the Company and its subsidiaries have implemented backup and disaster recovery
technology consistent with industry standards and practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(dd) <FONT STYLE="font-size: 10pt"><U>Title
to Real and Personal Property</U>. The Company and each of its subsidiaries have good and marketable title in and (in the case of
real property) to, or have valid and marketable rights to lease or otherwise use, all items of real or personal property which are
material to the business of the Company and its subsidiaries taken as a whole, in each case free and clear of all liens,
encumbrances, security interests, claims and defects that (i) do not, singularly or in the aggregate, materially affect the value of
such property and do not materially interfere with the use made and proposed to be made of such property by the Company or any of
its subsidiaries or (ii) would not reasonably be expected, singularly or in the aggregate, to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ee) <FONT STYLE="font-size: 10pt"><U>No
Labor Dispute</U>. There is (A) no significant unfair labor practice complaint pending against the Company, or any of its
subsidiaries, nor to the Company&rsquo;s Knowledge, threatened against it or any of its subsidiaries, before the National Labor
Relations Board, any state or local labor relation board or any foreign (including Israeli) labor relations board, and no
significant grievance or significant arbitration proceeding arising out of or under any collective bargaining agreement is so
pending against the Company or any of its subsidiaries, or, to the Company&rsquo;s Knowledge, threatened against it or any of its
subsidiaries and (B) no labor disturbance by or dispute with, employees of the Company or any of its subsidiaries exists or, to the
Company&rsquo;s Knowledge, is contemplated or threatened, and the Company is not aware of any existing or imminent labor disturbance
by the employees of any of its or its subsidiaries&rsquo; principal suppliers, manufacturers, customers or contractors, that would
reasonably be expected, singularly or in the aggregate, to have a Material Adverse Effect. The Company is not aware that any key
employee or significant group of employees of the Company or any of its subsidiaries plans to terminate employment with the Company
or any such subsidiary. All obligations of the Company to provide statutory severance pay to all its currently engaged employees in
Israel (&ldquo;<B><I>Israeli Employees</I></B>&rdquo;) are in accordance with Section 14 of the Israeli Severance Pay Law, 5723-1963
(the &ldquo;<B><I>Severance Pay Law</I></B>&rdquo;) and are fully funded or, if not required to be funded, are fully accrued on the
Company&rsquo;s financial statements, and all such Israeli Employees have been subject to the provisions of Section 14 of the
Severance Pay Law with respect to their entire salary, as defined under the Severance Pay Law, from the date of commencement of
their employment with the Company, and the Company has been in compliance with the requirements for a Section 14 arrangement with
respect to severance pay with respect to 100% of such salary for which severance pay may be due under the Severance Pay Law; and all
amounts that the Company is required by contract or applicable law either (A) to deduct from Israeli Employees&rsquo; salaries
and/or to transfer to such Israeli Employees&rsquo; pension or provident, life insurance, incapacity insurance, advance study fund
or other similar funds or insurance or (B) to withhold from its Israeli Employees&rsquo; salaries and benefits (including any other
income in cash or in kind) and to pay to any Israeli governmental authority as required by applicable Israeli tax law and
regulations, have, in each case, been duly deducted, transferred, withheld and paid, and the Company has no outstanding obligation
to make any such deduction, transfer, withholding or payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ff) <FONT STYLE="font-size: 10pt"><U>Compliance
with ERISA</U>. No &ldquo;prohibited transaction&rdquo; (as defined in Section 406 of the Employee Retirement Income Security Act of
1974, as amended, including the regulations and published interpretations thereunder (&ldquo;<B><I>ERISA</I></B>&rdquo;), or Section
4975 of the Internal Revenue Code of 1986, as amended from time to time (the &ldquo;<B><I>Code</I></B>&rdquo;)) or
&ldquo;accumulated funding deficiency&rdquo; (as defined in Section 302 of ERISA) or any of the events set forth in Section 4043(b)
of ERISA (other than events with respect to which the thirty (30)-day notice requirement under Section 4043 of ERISA has been
waived) has occurred or would reasonably be expected to occur with respect to any employee benefit plan of the Company or any of its
subsidiaries which would, singularly or in the aggregate, have a Material Adverse Effect. Each employee benefit plan of the Company
or any of its subsidiaries is in compliance in all material respects with applicable law, including ERISA and the Code. The Company
and its subsidiaries have not incurred and could not reasonably be expected to incur liability under Title IV of ERISA with respect
to the termination of, or withdrawal from, any pension plan (as defined in ERISA). Each pension plan for which the Company or any of
its subsidiaries would have any liability that is intended to be qualified under Section 401(a) of the Code is so qualified, and
nothing has occurred, whether by action or by failure to act, which could, singularly or in the aggregate, cause the loss of such
qualification. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(gg) <FONT STYLE="font-size: 10pt"><U>Environmental
Laws and Hazardous Materials</U>. Except as would not, singularly or in the aggregate, reasonably be expected to have a Material
Adverse Effect, (A) there has been no storage, generation, transportation, handling, treatment, disposal, discharge, emission, or
other release of any kind of toxic or other wastes or other hazardous substances by, due to, or caused by the Company or any of its
subsidiaries (or, to the Company&rsquo;s Knowledge, any other entity for whose acts or omissions the Company or any of its
subsidiaries is or may otherwise be liable) upon any of the property now or previously owned or leased by the Company or any of its
subsidiaries, or upon any other property, in violation of any law, statute, ordinance, rule, regulation, order, judgment, decree or
permit or which would, under any law, statute, ordinance, rule (including rule of common law), regulation, order, judgment, decree
or permit, give rise to any liability; and (B) there has been no disposal, discharge, emission or other release of any kind onto
such property or into the environment surrounding such property of any toxic or other wastes or other hazardous substances with
respect to which the Company or any of its subsidiaries has Knowledge. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(hh) <FONT STYLE="font-size: 10pt"><U>Taxes</U>.
The Company and its subsidiaries each (i) have timely filed all necessary federal, state, local and foreign (including Israeli) tax
returns, and all such returns were true, complete and correct, (ii) have paid all federal, state, local and foreign (including
Israeli) taxes, for which it is liable, including, without limitation, all sales and use taxes and all taxes which the Company or
any of its subsidiaries is obligated to withhold from amounts owing to employees, creditors and third parties, and (iii) do not have
any tax deficiency or claims outstanding or assessed or, to its Knowledge, proposed against any of them, except those, in each of
the cases described in clauses (i), (ii) and (iii) above, that would not, singularly or in the aggregate, have a Material Adverse
Effect. The Company and each of its subsidiaries is and have at all times been resident for tax purposes in their jurisdiction of
incorporation and are not and have not been treated as resident in any other jurisdiction for any tax purpose (including any double
taxation arrangement) and neither the Company nor any of its subsidiaries has received any written claim from any governmental or
regulatory authority that the Company or any of its subsidiaries is or may be subject to tax or required to file a tax return in a
jurisdiction where it does not file tax returns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ii) <U>Insurance</U>. The Company and
each of its subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as is customary for the conduct of
their respective businesses and the value of their respective properties. Neither the Company nor any of its subsidiaries has any reason
to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect. Neither the
Company nor any of its subsidiaries has received written notice from any insurer, agent of such insurer or the broker of the Company or
any of its subsidiaries that any material capital improvements or any other material expenditures (other than premium payments) are required
or necessary to be made in order to continue such insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(jj) <FONT STYLE="font-size: 10pt"><U>Accounting
Controls</U>. The Company and each of its subsidiaries maintains a system of &ldquo;internal control over financial reporting&rdquo;
(as such term is defined in Rule 13a-15(f) of the General Rules and Regulations under the Exchange Act (the &ldquo;<B><I>Exchange
Act Rules</I></B>&rdquo;)) that complies with the requirements of the Exchange Act and has been designed by their respective
principal executive and principal financial officers, or under their supervision, to provide reasonable assurances that (i)
transactions are executed in accordance with management&rsquo;s general or specific authorizations; (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (iii)
access to assets is permitted only in accordance with management&rsquo;s general or specific authorization; (iv) the recorded
accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to
any differences and (v) interactive data in eXtensible Business Reporting Language included or incorporated by reference in the
Registration Statement fairly presents the Commission&rsquo;s rules and guidelines applicable thereto. The Company&rsquo;s internal
control over financial reporting is effective. Except as described in the General Disclosure Package, since the end of the
Company&rsquo;s most recent audited fiscal year, there has been (A) no material weakness in the Company&rsquo;s internal control
over financial reporting (whether or not remediated) and (B) no change in the Company&rsquo;s internal control over financial
reporting that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over
financial reporting. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(kk) <FONT STYLE="font-size: 10pt"><U>Disclosure
Controls</U>. The Company and its subsidiaries maintain disclosure controls and procedures (as such is defined in Rule 13a-15(e) of
the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been
designed to ensure that information required to be disclosed by the Company and its subsidiaries in reports that they file or submit
under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&rsquo;s
rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the
Company&rsquo;s management as appropriate to allow timely decisions regarding disclosures. The Company and its subsidiaries have
conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ll) <FONT STYLE="font-size: 10pt"><U>Minute
Books</U>. The minute books of the Company have been made available to the Underwriters and counsel for the Underwriters, and such books
(i) contain a complete summary of all meetings and actions of the board of directors (including each board committee) and shareholders
of the Company (or analogous governing bodies and interest holders, as applicable) since the time of its respective incorporation or organization
through the date of the latest meeting and action, and (ii) accurately in all material respects reflect all transactions referred to in
such minutes. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(mm) <FONT STYLE="font-size: 10pt"><U>No
Undisclosed Relationships</U>. No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries on
the one hand, and the directors, officers, shareholders (or analogous interest holders), customers or suppliers of the Company or any
of its affiliates on the other hand, which is required to be described in the General Disclosure Package and the Prospectus or a document
incorporated by reference therein and which is not so described. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(nn) <FONT STYLE="font-size: 10pt"><U>No
Registration Rights</U>. No person or entity has the right to require registration of Ordinary Shares or other securities of the Company
or any of its subsidiaries because of the filing or effectiveness of the Registration Statement or the offering to which this Agreement
relates, except for persons and entities who have expressly waived such right in writing or who have been given timely and proper written
notice and have failed to exercise such right within the time or times required under the terms and conditions of such right. Except as
described in the General Disclosure Package, there are no persons with registration rights or similar rights to have any securities registered
by the Company or any of its subsidiaries under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(oo) <FONT STYLE="font-size: 10pt"><U>Margin
Rules</U>. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in
the General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve
system or any other regulation of such Board of Governors. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(pp) <FONT STYLE="font-size: 10pt"><U>No
Broker&rsquo;s Fees</U>. Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any
person (other than this Agreement) that would give rise to a valid claim against the Company or any of its subsidiaries or the Underwriters
for a brokerage commission, finder&rsquo;s fee or like payment in connection with the offering and sale of the Shares or any transaction
contemplated by this Agreement, the Registration Statement, the General Disclosure Package or the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(qq) <FONT STYLE="font-size: 10pt"><U>No
Restrictions on Subsidiaries</U>. Except as described in the General Disclosure Package and the Prospectus, no subsidiary of the Company
is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, from paying
any dividends to the Company, from making any other distribution on such subsidiary&rsquo;s share capital, from repaying to the Company
any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&rsquo;s properties or assets to
the Company or any other subsidiary of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(rr) <FONT STYLE="font-size: 10pt"><U>Stamp
Taxes</U>. No transaction, documentary, stamp, registration, issuance or transfer taxes or similar taxes, fees, fines, charges or duties
(including interest, penalties and additions to tax thereto) (&ldquo;<B><I>Stamp Taxes</I></B>&rdquo;) are payable by or on behalf of
the Underwriters in the State of Israel or any political subdivision or taxing authority thereof in connection with (i) the authorization,
issuance, sale and delivery of the Shares by the Company; (ii) the sale and delivery by the Underwriters of the Shares to purchasers thereof;
or (iii) the execution, delivery and performance of, and the consummation of the transactions contemplated by, this Agreement or any other
document to be furnished hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ss) <FONT STYLE="font-size: 10pt"><U>PFIC</U>.
Based on the Company&rsquo;s most recent audited financial statements and relevant market data, the Company has determined that it is
not a Passive Foreign Investment Company (&ldquo;<B><I>PFIC</I></B>&rdquo;) within the meaning of Section 1296 of the United States Internal
Revenue Code of 1966, and the Company is presently not likely to become a PFIC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(tt) <FONT STYLE="font-size: 10pt"><U>Forward-Looking
Statements</U>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in either the General Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has
been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(uu) <FONT STYLE="font-size: 10pt"><U>Listing</U>.
The Company is subject to and in compliance in all material respects with the reporting requirements of Section 13 or Section 15(d) of
the Exchange Act. The Ordinary Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange Act and are listed on the Nasdaq
Global Select Market and the &nbsp;TASE (each, an &ldquo;<B><I>Exchange</I></B>&rdquo; and collectively, the &ldquo;<B><I>Exchanges</I></B>&rdquo;),
and the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Ordinary
Shares under the Exchange Act or delisting the Ordinary Shares from either Exchange, nor has the Company received any notification that
the Commission, FINRA, the Israel Securities Authority or the TASE is contemplating terminating such registration or listings. The Company
is in compliance with the applicable listing requirements of the Exchanges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(vv) <FONT STYLE="font-size: 10pt"><U>Sarbanes-Oxley
Act</U>. There is and has been no failure on the part of the Company or, to the Company&rsquo;s Knowledge, any of the Company&rsquo;s
officers or directors, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated in connection therewith, including Section 402 related to loans and Sections 302 and 906 related to certifications. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ww) <FONT STYLE="font-size: 10pt"><U>No
Unlawful Payments</U>. Neither the Company nor any of its subsidiaries nor, to the Company&rsquo;s Knowledge, any directory, officer,
employee, agent, affiliate or other person acting on behalf of the Company or any subsidiary, has (i) used any corporate funds for unlawful
contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any direct or indirect unlawful
payment to foreign (including Israeli) or domestic government officials or employees, political parties or campaigns, political party
officials, or candidates for political office from corporate funds, (iii) violated or is in violation of any provision of the U.S. Foreign
Corrupt Practices Act of 1977, as amended, or any applicable anti-corruption laws, rules, or regulation of any other jurisdiction in which
the Company or any subsidiary is organized or conducts business, or (iv) made any other unlawful bribe, rebate, payoff, influence payment,
kickback, or other unlawful payment to any person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(xx) <FONT STYLE="font-size: 10pt"><U>Statistical
and Market Data</U>. The statistical and market related data included in the Registration Statement, the General Disclosure Package and
the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate, and such data agree with the
sources from which they are derived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(yy) <FONT STYLE="font-size: 10pt"><U>Compliance
with Money Laundering Laws</U>. The operations of the Company and its subsidiaries are and have been conducted at all times in the past
five (5) years in material compliance with all applicable financial recordkeeping and reporting requirements, including those of the U.S.
Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept
and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), the Israeli Prohibition on Money Laundering Law, 5760-2000, the Israeli Prohibition
on Money Laundering Order, 5761-2001, the Israeli Counter-Terrorism Law, 5776-2016, and any other applicable anti-money laundering laws
or regulations of jurisdictions where the Company and its subsidiaries are organized or conduct business (collectively, the &ldquo;<B><I>Anti-Money
Laundering Laws</I></B>&rdquo;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or
any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the Knowledge
of the Company, threatened. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><U>(zz) Compliance with Sanctions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)</TD><TD STYLE="text-align: justify">Neither the Company nor any of its subsidiaries, nor any director,
officer or employee thereof, nor, to the Company&rsquo;s Knowledge, any agent, affiliate, representative or other person acting on behalf
of the Company or any of its subsidiaries, is an individual or entity (&ldquo;<B><I>Person</I></B>&rdquo;) that is, or is owned 50% or
more or controlled by a Person that is: (i) the target of any economic, financial or trade sanctions administered or enforced by the
U.S. Department of Treasury&rsquo;s Office of Foreign Assets Control (&ldquo;<B><I>OFAC</I></B>&rdquo;), the United Nations Security
Council (&ldquo;<B><I>UNSC</I></B>&rdquo;), the European Union (&ldquo;<B><I>EU</I></B>&rdquo;), His Majesty&rsquo;s Treasury (&ldquo;<B><I>HMT</I></B>&rdquo;),
the Swiss Secretariat of Economic Affairs, or subject to the Israeli Trade with the Enemy Ordinance, 1939 (collectively, &ldquo;<B><I>Sanctions</I></B>&rdquo;),
nor (ii) located, organized or resident in a country or territory that is the subject of comprehensive Sanctions (including, as of the
date of this Agreement, the so-called Donetsk People&rsquo;s Republic, the so-called Luhansk People&rsquo;s Republic, the Crimea Region
of Ukraine, the non-government controlled areas of the Zaporizhzhia and Kherson Regions, Cuba, Iran, North Korea and Syria) (collectively
&ldquo;<B><I>Sanctioned Jurisdictions</I></B>&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(B)</TD><TD STYLE="text-align: justify">The Company will not, directly or knowingly indirectly, use the proceeds of the offering, or lend, contribute
or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person: (i) to fund or facilitate any activities
or business of or with any Person that, at the time of such funding or facilitation, is the target of Sanctions, or in any Sanctioned
Jurisdiction, in either case in violation of Sanctions; or (ii) in any other manner that would result in a violation of Sanctions by any
Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(C)</TD><TD STYLE="text-align: justify">Since April 24, 2019, the Company and its subsidiaries have not knowingly engaged in, are not now knowingly
engaged in, and will not engage in, any direct or indirect dealings or transactions with any Person that at the time of the dealing or
transaction is or was the target of Sanctions or any Sanctioned Jurisdiction, in either case in violation of Sanctions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(aaa) <FONT STYLE="font-size: 10pt"><U>No
Associated Persons; FINRA Matters</U>. Neither the Company nor any of its affiliates (within the meaning of FINRA Rule 5121(f)(1)) directly
or indirectly controls, is controlled by, or is under common control with, or is an associated person (within the meaning of Article I,
Section 1(ee) of the By-laws of FINRA) of, any member firm of FINRA. The Company qualifies as an &ldquo;experienced issuer&rdquo; (within
the meaning of FINRA Conduct Rule 5110(j)(6)) for purposes of the exemption from filing under FINRA Conduct Rule 5110(h)(1)(C).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(bbb) <FONT STYLE="font-size: 10pt"><U>Certification
Regarding Beneficial Owners</U>. The Company has delivered to the Representatives a properly completed and executed Certification Regarding
Beneficial Owners of Legal Entity Customers (to the extent requested by the Representatives), and, if required, copies of identifying
documentation. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ccc) <FONT STYLE="font-size: 10pt"><U>No
Acquisitions or Dispositions</U>. There are no contracts, letters of intent, term sheets, agreement, arrangements or understandings with
respect to the direct or indirect acquisition or disposition by the Company or any of its subsidiaries of material interests in real
or personal property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ddd) <FONT STYLE="font-size: 10pt"><U>Export
and Import Laws</U>. Except as otherwise disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, of
the Company and the subsidiaries, and, to the Company&rsquo;s Knowledge, each of their affiliates and any director, officer, agent or
employee of, or other person acting on behalf of, the Company has acted at all times in the past five (5) years in compliance with applicable
Export and Import Laws (as defined below) and there are no claims, complaints, charges, investigations or proceedings pending or expected
or, to the knowledge of the Company, threatened between the Company or any of the subsidiaries and any governmental authority under any
Export or Import Laws. The term &ldquo;<B><I>Export and Import Laws</I></B>&rdquo; means the Arms Export Control Act, the International
Traffic in Arms Regulations, the Export Control Reform Act, the Export Administration Regulations, and all other import, customs, and
export control laws and regulations of the United States Government, and all similar laws and regulations of any governmental authority
(including Israeli) with jurisdiction over the Company and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(eee) <FONT STYLE="font-size: 10pt"><U>Outbound
Investment Security Program</U>. Neither the Company nor any of its subsidiaries is a &ldquo;covered foreign person&rdquo;, as that term
is defined in 31 C.F.R. &sect; 850.209. Neither the Company nor any of its subsidiaries currently engages, or has plans to engage, directly
or indirectly, in a &ldquo;covered activity&rdquo;, as that term is defined in in 31 C.F.R. &sect; 850.208 (&ldquo;<B><I>Covered Activity</I></B>&rdquo;).
The Company does not have any joint ventures that engages in or plans to engage in any Covered Activity. The Company also does not, directly
or indirectly, hold a board seat on, have a voting or equity interest in, or have any contractual power to&nbsp;direct or cause the direction
of the management or policies of any person or persons that engages or plans to engage in any Covered Activity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(fff) <FONT STYLE="font-size: 10pt"><U>Immunity</U>.
Neither the Company nor any of its subsidiaries or assets has any immunity from the jurisdiction of any court or from any legal process
(whether through service or notice, attachment prior to judgement, attachment in aid of execution or otherwise) under the laws of the
State of Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ggg) <FONT STYLE="font-size: 10pt"><U>Valid
Choice of Law; Enforceability</U>. The choice of laws of the State of New York as the governing law of this Agreement is a valid choice
of law under the laws of the State of Israel and will be honored by the courts of Israel. The Company has the power to submit, and pursuant
to Section 18 of this Agreement, has legally, validly, effectively and irrevocably submitted to the personal jurisdiction of the Federal
and state courts in the Borough of Manhattan in The City of New York (each, a &ldquo;<B><I>New York Court</I></B>&rdquo;) and has validly
and irrevocably waived any objection to the laying of venue of any suit, action or proceeding brought in such court. Any final judgment
for a fixed or readily calculable sum of money rendered by a New York Court having jurisdiction under its own domestic laws and recognized
by the Israeli courts as having jurisdiction to give such final judgment in respect of any suit, action or proceeding against the Company
based upon this Agreement and any instruments or agreements entered into for the consummation of the transactions contemplated herein
would be declared enforceable against the Company in the Israeli courts. The Company is not aware of any reason why the enforcement in
Israel of such a New York Court judgment would be, as of the date hereof, contrary to the public policy of the State of Israel. The Company
has the power to designate, appoint and authorize, and pursuant to Section 18 of this Agreement, has legally, validly, effectively and
irrevocably designated, appointed and authorized an agent for service of process in any action arising out of or relating to this Agreement,
and service of process effected on such authorized agent will be effective to confer valid personal jurisdiction over the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(hhh) <FONT STYLE="font-size: 10pt"><U>Dividends</U>.
Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, no approvals are currently required
by any governmental authority in the State of Israel in order for the Company to pay dividends or other distributions declared by the
Company to the holders of Shares. Under current laws and regulations of the State of Israel and any political subdivision thereof, any
amount payable with respect to the Shares upon liquidation of the Company or upon redemption thereof and dividends and other distributions
declared and payable on the share capital of the Company may be paid by the Company in United States dollars or euros and freely transferred
out of the State of Israel and without the necessity of obtaining any governmental authorization in the State of Israel or any political
subdivision thereof or therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(iii) <FONT STYLE="font-size: 10pt"><U>Effect
of Certificates</U>. Any certificate signed by or on behalf of the Company and delivered to the Representatives or to counsel for the
Underwriters shall be deemed to be a representation and warranty by the Company to each Underwriter as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(jjj) <FONT STYLE="font-size: 10pt"><U>Grants
and Incentives</U>. Neither the Company nor any of its subsidiaries (i) has received and/or applied for any material grants, incentives,
benefits (including tax benefits) or subsidies from any governmental body, agency or authority, including without limitation, the Israel
Innovation Authority, nor has any outstanding obligations towards such governmental body, agency or authority in each case, except as
disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, nor (ii) is in violation of any condition,
requirement or undertaking with respect to (A) any funding, benefits or incentives granted to the Company or any of its subsidiaries under
the Law for Encouragement of Industrial Research, Development and Technological Innovation, 5744-1984 and the regulations, rules and circulars
promulgated thereunder, including any instrument of approval or tax ruling granted to any of them in connection therewith, or (B) any
grants, benefits, reduced tax rates or incentives provided to or claimed by the Company or any of its subsidiaries under the&nbsp;Law
for Encouragement of Capital Investments, 5719-1959 (the &ldquo;<B><I>Investment Law</I></B>&rdquo;) except, in each case, such violation
that would not reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received
any written notice denying, revoking or adversely modifying any &ldquo;approved enterprise,&rdquo; &ldquo;benefited enterprise,&rdquo;
&ldquo;preferred enterprise,&rdquo; &ldquo;preferred technological enterprise,&rdquo; &ldquo;special preferred technological enterprise,&rdquo;
or &ldquo;industrial company&rdquo; status with respect to any of them or their facilities or operations or any tax benefits claimed or
received by the Company or any of its subsidiaries (including, in all such cases, notice of proceedings or investigations related thereto).
All information supplied by the Company or any of its subsidiaries with respect to the applications or notifications relating to such
status, funding, grants, benefits (including tax benefits), incentives or subsidies, was true, correct and complete in all material respects
when supplied to the appropriate authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(kkk) <FONT STYLE="font-size: 10pt"><U>Industrial
Company</U>. The Company qualified as an &ldquo;Industrial Company&rdquo; within the definition of the Law for the Encouragement of Industry
(Taxes), 5729-1969 in each of the last five years; and absent a change in such law, the Company intends to continue to so qualify for
2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-variant: small-caps">3.
<I>Purchase, Sale and Delivery of Offered Shares. </I></FONT>On the basis of the representations, warranties and agreements herein contained,
but subject to the terms and conditions herein set forth, the Company agrees to issue and sell to the Underwriters, and the Underwriters
agree, severally and not jointly, to purchase from the Company the respective numbers of Firm Shares set forth opposite the names of the
Underwriters in <U>Schedule A</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purchase price per share
to be paid by the Underwriters to the Company for the Shares will be $7.56 per share (the &ldquo;<B><I>Purchase Price</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will deliver the
Firm Shares to the Representatives for the respective accounts of the several Underwriters, through the facilities of The Depository Trust
Company or, at the election of the Representatives, in the form of definitive certificates, in each such case, issued in such names and
in such denominations as the Representatives may direct by notice in writing to the Company given at or prior to 12:00 Noon, New York
time, on the second (2<SUP>nd</SUP>) full business day preceding the Closing Date against payment of the aggregate Purchase Price therefor
by wire transfer in federal (same day) funds to an account at a bank specified by the Company payable to the order of the Company. Time
shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further condition of the obligations
of each Underwriter hereunder. The time and date of the delivery and closing shall be at 10:00 A.M., New York time, on June 26, 2025,
in accordance with Rule 15c6-1 of the Exchange Act. The time and date of such payment and delivery are herein referred to as the &ldquo;<B><I>Closing
Date</I></B>&rdquo;. The Closing Date and the location of delivery of, and the form of payment for, the Firm Shares may be varied by agreement
between the Company and the Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company, in the event
the Representatives elect to have the Underwriters take delivery of definitive certificates instead of delivery from the Company of the
certificates through the facilities of The Depository Trust Company, shall make certificates for the Firm Shares available to the Representatives
for examination on behalf of the Underwriters in New York, New York at least one (1) full business day prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Underwriters may purchase
all or less than all of the Optional Shares. The price per share to be paid for the Optional Shares shall be the Purchase Price. The Company
agrees to sell to the Underwriters the number of Optional Shares specified in the written notice delivered by the Representatives to the
Company described below and the Underwriters agree, severally and not jointly, to purchase such Optional Shares. The option granted hereby
may be exercised as to all or any part of the Optional Shares at any time, and from time to time, <I>provided however</I>, that notice
of such exercise must be delivered not more than thirty (30) days subsequent to the date of this Agreement. No Optional Shares shall be
sold and delivered unless the Firm Shares previously have been, or simultaneously are, sold and delivered. The right to purchase the Optional
Shares or any portion thereof may be surrendered and terminated at any time upon notice by Representatives to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The option granted hereby
shall be exercised by written notice being given to the Company by the Representatives setting forth the number of Optional Shares to
be purchased by the Underwriters and the date and time for delivery of and payment for the Optional Shares. Each date and time for delivery
of and payment for the Optional Shares (which may be the Closing Date, but not earlier) is herein called the &ldquo;<B><I>Option Closing
Date</I></B>&rdquo; and shall in no event be earlier than one (1) business days nor later than five (5) business days after written notice
is given. The Option Closing Date and the Closing Date are herein called the &ldquo;<B><I>Closing Dates</I></B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will deliver the
Optional Shares to the Representatives for the respective accounts of the several Underwriters through the facilities of The Depository
Trust Company or, at the election of the Representatives, in the form of definitive certificates, issued in such names and in such denominations
as the Representatives may direct by notice in writing to the Company given at or prior to 12:00 Noon, New York time, on the second (2<SUP>nd</SUP>)
full business day preceding the Option Closing Date against payment of the aggregate Purchase Price therefor by wire transfer in federal
(same day) funds to an account at a bank acceptable to the Representatives payable to the order of the Company, all at the offices of
DLA Piper LLP (US). Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further
condition of the obligations of each Underwriter hereunder. The Company, in the event the Representatives elect to have the Underwriters
take delivery of definitive certificates instead of delivery from the Company of the certificates through the facilities of The Depository
Trust Company, shall make the certificates for the Optional Shares available to the Representatives for examination on behalf of the Underwriters
in New York, New York not later than 10:00 A.M., New York Time, at least one (1) full business day prior to the Option Closing Date. The
Option Closing Date and the location of delivery of, and the form of payment for, the Optional Shares may be varied by agreement between
the Company and the Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The several Underwriters propose
to offer the Shares for sale upon the terms and conditions set forth in the Prospectus. The Company acknowledges and agrees that the Underwriters
may offer and sell Shares to or through any affiliate of an Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -4.5pt"><FONT STYLE="font-variant: small-caps"><I>4.
Further Agreements Of The Company. </I></FONT>The Company agrees with the several Underwriters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -4.5pt"><FONT STYLE="font-variant: small-caps"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(a) <FONT STYLE="font-size: 10pt"><U>Required
Filings; Amendments or Supplements; Notice to the Representative</U>. To prepare a Rule 462(b) Registration Statement, if necessary,
in a form approved by the Representatives and file such Rule 462(b) Registration Statement with the Commission by 10:00 P.M., New York
time, on the date hereof, and the Company shall at the time of filing either pay to the Commission the filing fee for such Rule 462(b)
Registration Statement or give irrevocable instructions for the payment of such fee pursuant to Rule 111(b) under the Rules and Regulations;
to prepare the Prospectus in a form approved by the Representatives containing information previously omitted at the time of effectiveness
of the Registration Statement in reliance on Rule 430B of the Rules and Regulations and to file such Prospectus pursuant to Rule 424(b)
of the Rules and Regulations not later than the second business (2<SUP>nd</SUP>) day following the execution and delivery of this Agreement
or, if applicable, such earlier time as may be required by the Securities Act; to notify the Representatives immediately of the Company&rsquo;s
intention to file or prepare any supplement or amendment to the Registration Statement or to the Prospectus and to make no amendment
or supplement to the Registration Statement, the General Disclosure Package or to the Prospectus to which the Representatives shall reasonably
object by notice to the Company after a reasonable period to review; to advise the Representatives, promptly after it receives notice
thereof, of the time when any amendment to the Registration Statement has been filed or becomes effective or any supplement to the General
Disclosure Package or the Prospectus or any amended Prospectus or any Issuer Free Writing Prospectus has been filed and to furnish the
Underwriters with copies thereof; to file promptly all material required to be filed by the Company with the Commission pursuant to Rules
433(d) or 163(b)(2) of the Rules and Regulations, as the case may be; to file promptly all reports required to be filed by the Company
with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for
so long as the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules and Regulations) is required
in connection with the offering or sale of the Shares; to advise the Representatives, promptly after it receives notice thereof, of the
issuance by the Commission of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus, any Issuer
Free Writing Prospectus or the Prospectus, of the suspension of the qualification of the Shares for offering or sale in any jurisdiction,
of the initiation or threatening of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing
of the Registration Statement, the General Disclosure Package or the Prospectus or for additional information; and, in the event of the
issuance of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus
or the Prospectus or suspending any such qualification, and promptly to use its best efforts to obtain the withdrawal of such order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(b) <FONT STYLE="font-size: 10pt"><U>Permitted
Free Writing Prospectus</U>. The Company represents and agrees that, unless it obtains the prior written consent of the Representatives
not to be unreasonably withheld, conditioned or delayed, it has not made and will not, other than the final term sheet prepared and filed
pursuant to Section&nbsp;4(e) hereof, make any offer relating to the Shares that would constitute a &ldquo;free writing prospectus&rdquo;
as defined in Rule 405 of the Rules and Regulations unless the prior written consent of the Representatives has been received (each, a
&ldquo;<B><I>Permitted Free Writing Prospectus</I></B>&rdquo;); <I>provided</I> that the prior written consent of the Representatives
hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in <U>Schedule B</U> hereto. The
Company represents that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an Issuer Free Writing
Prospectus, comply with the requirements of Rules 164 and 433 of the Rules and Regulations applicable to any Issuer Free Writing Prospectus,
including the requirements relating to timely filing with the Commission, legending and record keeping and will not take any action that
would result in an Underwriter or the Company being required to file with the Commission pursuant to Rule 433(d) of the Rules and Regulations
a free writing prospectus prepared by or on behalf of such Underwriter that such Underwriter otherwise would not have been required to
file thereunder. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(c) <FONT STYLE="font-size: 10pt"><U>Ongoing
Compliance</U>. If at any time prior to the date when a prospectus relating to the Shares is required to be delivered (or in lieu thereof,
the notice referred to in Rule 173(a) under the Securities Act) any event occurs or condition exists as a result of which the Prospectus
as then amended or supplemented would include any untrue statement of a material fact, or omit to state any material fact necessary to
make the statements therein, in light of the circumstances under which they were made when the Prospectus is delivered (or in lieu thereof,
the notice referred to in Rule 173(a) of the Rules and Regulations), not misleading, or if it is necessary at any time to amend or supplement
the Registration Statement or the Prospectus or to file under the Exchange Act any document incorporated by reference in the Prospectus
to comply with the Securities Act or the Exchange Act, that the Company will promptly notify the Representatives thereof and upon their
request will prepare an appropriate amendment or supplement or upon their request make an appropriate filing pursuant to Section&nbsp;13
or 14 of the Exchange Act in form and substance satisfactory to the Representatives which will correct such statement or omission or effect
such compliance and will use its reasonable best efforts to have any amendment to the Registration Statement declared effective as soon
as possible. The Company will furnish without charge to each Underwriter and to any dealer in securities as many copies as the Representatives
may from time to time reasonably request of such amendment or supplement. In case any Underwriter is required to deliver a prospectus
(or in lieu thereof, the notice referred to in Rule 173(a) of the Rules and Regulations) relating to the Shares, the Company upon the
request of the Representatives will prepare promptly an amended or supplemented Prospectus as may be necessary to permit compliance with
the requirements of Section 10(a)(3) of the Securities Act and deliver to such Underwriter as many copies as such Underwriter may request
of such amended or supplemented Prospectus complying with Section 10(a)(3) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(d) <FONT STYLE="font-size: 10pt"><U>Amendment
to General Disclosure Package</U>. If the General Disclosure Package is being used to solicit offers to buy the Shares at a time when
the Prospectus is not yet available to prospective purchasers and any event shall occur as a result of which, in the judgment of the Company
or in the reasonable opinion of the Representatives, it becomes necessary to amend or supplement the General Disclosure Package in order
to make the statements therein, in the light of the circumstances then prevailing, not misleading, or to make the statements therein not
conflict with the information contained or incorporated by reference in the Registration Statement then on file and not superseded or
modified, or if it is necessary at any time to amend or supplement the General Disclosure Package to comply with any law, the Company
promptly will either (i) prepare, file with the Commission (if required) and furnish to the Underwriters and any dealers an appropriate
amendment or supplement to the General Disclosure Package or (ii) prepare and file with the Commission an appropriate filing under the
Exchange Act which shall be incorporated by reference in the General Disclosure Package so that the General Disclosure Package as so amended
or supplemented will not, in the light of the circumstances then prevailing, be misleading or conflict with the Registration Statement
then on file, or so that the General Disclosure Package will comply with law. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(e) <FONT STYLE="font-size: 10pt"><U>Amendment
to Issuer Free Writing Prospectus</U>. If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs
an event or development as a result of which such Issuer Free Writing Prospectus conflicted or will conflict with the information contained
in the Registration Statement, Pricing Prospectus or Prospectus, including any document incorporated by reference therein and any prospectus
supplement deemed to be a part thereof and not superseded or modified or included or would include an untrue statement of a material fact
or omitted or would omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances prevailing at the subsequent time, not misleading, the Company has promptly notified or will promptly
notify the Representatives so that any use of the Issuer Free Writing Prospectus may cease until it is amended or supplemented and has
promptly amended or will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct
such conflict, untrue statement or omission. The foregoing sentence does not apply to statements in or omissions from any Issuer Free
Writing Prospectus in reliance upon, and in conformity with, written information furnished to the Company through the Representatives
by or on behalf of any Underwriter specifically for inclusion therein, which information the parties hereto agree is limited to the Underwriters&rsquo;
Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(f) <FONT STYLE="font-size: 10pt"><U>Delivery
of Registration Statement</U>. To the extent not available on the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval
system or any successor system (&ldquo;<B><I>EDGAR</I></B>&rdquo;), upon the request of the Representatives, to furnish promptly to the
Representatives and to counsel for the Underwriters a signed copy of the Registration Statement as originally filed with the Commission,
and of each amendment thereto filed with the Commission, including all consents and exhibits filed therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(g) <FONT STYLE="font-size: 10pt"><U>Delivery
of Copies</U>. Upon request of the Representatives, to the extent not available on EDGAR, to deliver promptly to the Representatives
in New York City such number of the following documents as the Representatives shall reasonably request: (i) conformed copies of the
Registration Statement as originally filed with the Commission (in each case excluding exhibits), (ii) each Preliminary Prospectus, (iii)
any Issuer Free Writing Prospectus, (iv) the Prospectus (the delivery of the documents referred to in clauses (i), (ii), (iii) and (iv)
of this paragraph (g) to be made not later than 10:00 A.M., New York time, on the business day following the execution and delivery of
this Agreement), (v) conformed copies of any amendment to the Registration Statement (excluding exhibits), (vi) any amendment or supplement
to the General Disclosure Package or the Prospectus (the delivery of the documents referred to in clauses (v) and (vi) of this paragraph
(g) to be made not later than 10:00 A.M., New York City time, on the business day following the date of such amendment or supplement),
and (vii) any document incorporated by reference in the General Disclosure Package or the Prospectus (excluding exhibits thereto) (the
delivery of the documents referred to in clause (vi) of this paragraph (g) to be made not later than 10:00 A.M., New York City time,
on the business day following the date of such document).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(h) <FONT STYLE="font-size: 10pt"><U>Earnings
Statement</U>. To make generally available to its shareholders as soon as practicable, but in any event not later than sixteen (16) months
after the effective date of the Registration Statement (as defined in Rule 158(c) of the Rules and Regulations), an earnings statement
of the Company and its subsidiaries (which need not be audited) complying with Section 11(a) of the Securities Act (including, at the
option of the Company, Rule 158).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(i) <FONT STYLE="font-size: 10pt"><U>Blue
Sky Compliance</U>. To take promptly from time to time such actions as the Representatives may reasonably request to qualify the Shares
for offering and sale under the securities or Blue Sky laws of such jurisdictions (domestic or foreign) as the Representatives may reasonably
designate and to continue such qualifications in effect, and to comply with such laws, for so long as required to permit the offer and
sale of Shares in such jurisdictions; <I>provided</I> that the Company and its subsidiaries shall not be obligated to (i) qualify as foreign
corporations in any jurisdiction in which they are not so qualified, (ii) file a general consent to service of process in any jurisdiction
or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(j) <FONT STYLE="font-size: 10pt"><U>Reports</U>.
Upon request, during the period of five (5) years from the date hereof, to deliver to each of the Underwriters, (i) as soon as they are
available, copies of all reports or other communications (financial or other) furnished to shareholders, and (ii) as soon as they are
available, copies of any reports and financial statements furnished or filed with the Commission or any national securities exchange on
which the Shares are listed. However, so long as the Company is subject to the reporting requirements of either Section 13 or Section
15(d) of the Exchange Act and is timely filing reports EDGAR, it is not required to furnish such reports or statements to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(k) <FONT STYLE="font-size: 10pt"><U>Lock-Up</U>.
During the period commencing on and including the date hereof and ending on and including the 75th day following the date of this Agreement,
(the &ldquo;<B><I>Lock-Up Period</I></B>&rdquo;) the Company will not, without the prior written consent of the Representatives (which
consent may be withheld at the sole discretion of the Representatives), directly or indirectly offer, sell (including, without limitation,
any short sale), assign, transfer, pledge, contract to sell, establish an open &ldquo;put equivalent position&rdquo; within the meaning
of Rule 16a-1(h) under the Exchange Act, or otherwise dispose of, or announce the offering of, or submit or file any registration statement
under the Securities Act in respect of, any Ordinary Shares, options, rights or warrants to acquire Ordinary Shares or securities exchangeable
or exercisable for or convertible into Ordinary Shares (other than is contemplated by this Agreement with respect to the Shares) or publicly
announce any intention to do any of the foregoing; <I>provided, however</I>, that the Company may (i) issue Ordinary Shares and options
to purchase Ordinary Shares, Ordinary Shares underlying options granted and other securities, each pursuant to any director or employee
share option plan, share ownership plan or dividend reinvestment plan of the Company in effect on the date hereof and described in the
General Disclosure Package; (ii) issue Ordinary Shares pursuant to the conversion of securities or the exercise of warrants, which securities
or warrants are outstanding on the date hereof and described in the General Disclosure Package (including the issuances of Ordinary Shares
upon the amendment or conversion of the Lynrock Note, as described in the General Disclosure Package); (iii) adopt a new equity incentive
plan, and file a registration statement on Form S-8 under the Securities Act to register the offer and sale of securities to be issued
pursuant to such new equity incentive plan, and issue securities pursuant to such new equity incentive plan (including, without limitation,
the issuance of Ordinary Shares upon the exercise of options or other securities issued pursuant to such new equity incentive plan). The
Company will cause each person and entity listed in <U>Schedule D</U> to furnish to the Representatives, prior to the Closing Date, a
&ldquo;lock-up&rdquo; agreement, substantially in the form of <U>Exhibit I</U> hereto. In addition, the Company will direct the transfer
agent to place stop transfer restrictions upon any such securities of the Company that are bound by such &ldquo;lock-up&rdquo; agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(l) <FONT STYLE="font-size: 10pt"><U>Delivery
of SEC Correspondence</U>. To supply the Underwriters with copies of all correspondence to and from, and all documents issued to and by,
the Commission in connection with the registration of the Shares under the Securities Act or any of the Registration Statement, any Preliminary
Prospectus or the Prospectus, or any amendment or supplement thereto or document incorporated by reference therein. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(m) <FONT STYLE="font-size: 10pt"><U>Stamp
Taxes</U>. Without duplication of any amounts that may be paid by the Company under Section 4 hereof, the Company will indemnify and hold
harmless the Underwriters and/or their affiliates against any Stamp Taxes imposed by the State of Israel or any other jurisdiction in
connection with (A) the authorization, issuance, sale and delivery of the Shares by the Company; (B) the sale and delivery by the Underwriters
and/or their affiliates of the Shares to purchasers thereof; or (C) the execution, delivery and performance of, and the consummation of
the transactions contemplated by, this Agreement or any other document to be furnished hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(n) <FONT STYLE="font-size: 10pt"><U>Payments
Free of Taxes</U>. All payments made or to be made, or deemed to be made, by or on behalf of the Company under this Agreement to an Underwriter
or its affiliates, directors, officers, managers, members, employees, representatives and agents and each person, if any, who controls
such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each a &ldquo;<B><I>Payee</I></B>&rdquo;)
shall be made exclusive of, free and clear of and without withholding or deduction for or on account of any present or future taxes, duties,
assessments or governmental charges of whatever nature imposed or levied by or on behalf of the State of Israel or any other jurisdiction
in which the Company is organized or incorporated, engaged in business for tax purposes or is otherwise resident for tax purposes or has
a permanent establishment, any jurisdiction from or through which a payment is made by or on behalf of the Company, or any political subdivision,
authority or agency in or of any of the foregoing having power to tax, unless the Company is or becomes required by law to withhold or
deduct such taxes, duties, assessments or governmental charges. In such event, the Company will pay such additional amounts as will result,
after all such withholdings or deductions (including, for the avoidance of doubt, from any additional amounts), in the receipt by each
Payee of the amounts that would otherwise have been received had no such deduction or withholding been required or made, provided, that
the Company shall not be liable to pay any such additional amounts to the extent that such taxes, duties, assessments, governmental charges,
withholding or deduction was imposed on such Payee solely as a result of such Payee being a tax resident of, being organized or incorporated
in, or having a permanent establishment in, such jurisdiction imposing such taxes, duties, assessments, governmental charges, withholding
or deduction or as a result of any present or former connection (other than any connection arising as a result of the execution and delivery
of, or performance of, its obligations under this Agreement or receipt of any payments or enforcement of rights hereunder) between the
Payee and such jurisdiction imposing such taxes, duties, assessments, governmental charges, withholding or deduction. Upon request, the
Company shall provide to the Representatives evidence of any amounts withheld or deducted pursuant to the terms of this Section and shall
also provide to the Representatives any tax receipt or other documentation issued by the appropriate governmental authorities with respect
to the payment of such amounts to such governmental authorities. If requested by the Company, the relevant Underwriter shall reasonably
cooperate with the Company, by providing reasonably required information for the Company that the relevant Underwriter is legally entitled
to provide and the provision of which does not cause a material prejudice to such Underwriter&rsquo;s legal or commercial position, to
the extent necessary, for the Company to obtain an exemption certificate from withholding or deduction in connection with the payments
under this Agreement. All sums payable or deemed payable by the Company under this Agreement shall be considered exclusive of value added
tax, sales tax or similar taxes, which taxes shall be borne, paid, collected and remitted by the Company, if and as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(o) <FONT STYLE="font-size: 10pt"><U>Press
Releases</U>. Prior to the Closing Date, not to issue any press release or other communication directly or indirectly or hold any press
conference with respect to the Company, its condition, financial or otherwise, or earnings, business affairs or business prospects (except
for routine oral marketing communications in the ordinary course of business and consistent with the past practices of the Company and
of which the Representatives are notified), without the prior consent of the Representatives, unless in the judgment of the Company and
its counsel, and after notification to the Representatives, such press release or communication is required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(p) <FONT STYLE="font-size: 10pt"><U>Compliance
with Regulation M</U>. Until the Underwriters shall have notified the Company of the completion of the resale of the Shares, that the
Company will not, and will use its reasonable best efforts to cause its affiliated purchasers (as defined in Regulation M under the Exchange
Act) not to, either alone or with one or more other persons, bid for or purchase, for any account in which it or any of its affiliated
purchasers has a beneficial interest, any Shares, or attempt to induce any person to purchase any Shares; and not to, and to use its reasonable
best efforts to cause its affiliated purchasers not to, make bids or purchase for the purpose of creating actual, or apparent, active
trading in or of raising the price of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(q) <FONT STYLE="font-size: 10pt"><U>Registrar
and Transfer Agent</U>. To maintain, at its expense, a registrar and transfer agent for the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(r) <FONT STYLE="font-size: 10pt"><U>Use
of Proceeds</U>. To apply the net proceeds from the sale of the Shares as set forth in the Registration Statement, the General Disclosure
Package and the Prospectus under the heading &ldquo;<I>Use of Proceeds</I>,&rdquo; and except as disclosed in the General Disclosure Package,
the Company does not intend to use any of the proceeds from the sale of the Shares hereunder to repay any outstanding debt owed to any
affiliate of any Underwriter. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(s) <FONT STYLE="font-size: 10pt"><U>Exchange
Listing</U>. To use its reasonable best efforts to list for quotation the Shares on the Nasdaq Global Select Market and the TASE.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(t) <FONT STYLE="font-size: 10pt"><U>Performance
of Covenants and Satisfaction of Conditions</U>. To use its reasonable best efforts to do and perform all things required to be done or
performed under this Agreement by the Company prior to each Closing Date and to satisfy all conditions precedent to the delivery of the
Firm Shares and the Optional Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><I>Payment
of Expenses</I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company agrees to pay, or reimburse
if paid by any Underwriter, whether or not the transactions contemplated hereby are consummated or this Agreement is terminated: (a) the
costs incident to the authorization, issuance, sale, preparation and delivery of the Shares and any taxes payable in that connection;
(b) the costs incident to the registration of the Shares under the Securities Act; (c) the costs incident to the preparation, printing
and distribution of the Registration Statement, the Base Prospectus, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the
General Disclosure Package, the Prospectus, any amendments, supplements and exhibits thereto or any document incorporated by reference
therein and the costs of printing, reproducing and distributing, this Agreement and any closing documents by mail, telex or other means
of communications; (d) the fees and expenses (including related fees and expenses of counsel for the Underwriters) incurred in connection
with securing any required review by FINRA of the terms of the sale of the Shares and any filings made with FINRA, up to an aggregate
of $20,000; (e) any applicable listing or other fees; (f) the fees and expenses (including related fees and expenses of counsel to the
Underwriters) of qualifying the Shares under the securities laws of the several jurisdictions as provided in Section 4(i) and of preparing,
printing and distributing wrappers, Blue Sky Memoranda and Legal Investment Surveys; (g) the cost of preparing and printing share certificates;
(h) all fees and expenses of the registrar and transfer agent of the Shares; (i) transaction related expenses incurred by the Underwriters
up to an aggregate of $30,000 (exclusive of the fees and expenses provided for in clause (d) above); (j) the costs and expenses of the
Company relating to investor presentations on any &ldquo;road show&rdquo; undertaken in connection with the marketing of the offering
of the Shares, including, without limitation, expenses associated with the preparation or dissemination of any electronic road show, expenses
associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road
show presentations with the prior approval of the Company, travel and lodging expenses of the officers of the Company and such consultants,
including the cost of any aircraft chartered in connection with the road show, and (k) all other costs and expenses incident to the offering
of the Shares or the performance of the obligations of the Company under this Agreement (including, without limitation, the fees and expenses
of the Company&rsquo;s counsel and the Company&rsquo;s independent accountants; <I>provided</I> that, except to the extent otherwise provided
in this Section 5 and in Sections 9 and 10, the Underwriters shall pay their own costs and expenses, including the fees and expenses of
their counsel not contemplated herein, and the expenses of advertising any offering of the Shares made by the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><I>6. Conditions
of Underwriters&rsquo; Obligations.</I></FONT> The respective obligations of the several Underwriters hereunder are subject to the accuracy,
when made and as of the Applicable Time and on such Closing Date, of the representations and warranties of the Company contained herein,
to the accuracy of the statements of the Company made in any certificates delivered to the Representatives or to counsel for the Underwriters,
to the performance by the Company of its obligations hereunder, and to each of the following additional terms and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(a) <FONT STYLE="font-size: 10pt"><U>Registration
Compliance; No Stop Orders</U>. The Registration Statement has become effective under the Securities Act, and no stop order suspending
the effectiveness of the Registration Statement or any part thereof, preventing or suspending the use of any Preliminary Prospectus,
the Prospectus or any Permitted Free Writing Prospectus or any part thereof shall have been issued and no proceedings for that purpose
or pursuant to Section 8A under the Securities Act shall have been initiated or threatened by the Commission, and all requests for additional
information on the part of the Commission (to be included or incorporated by reference in the Registration Statement or the Prospectus
or otherwise) shall have been complied with to the reasonable satisfaction of the Representatives; any Rule 462(b) Registration Statement,
each Issuer Free Writing Prospectus and the Prospectus shall have been filed with the Commission within the applicable time period prescribed
for such filing by, and in compliance with, the Rules and Regulations and in accordance with Section 4(a), and any Rule 462(b) Registration
Statement, shall have become effective immediately upon its filing with the Commission; and FINRA shall have raised no unresolved objection
to the fairness and reasonableness of the terms of this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(a) <FONT STYLE="font-size: 10pt"><U>No
Material Misstatements</U>. None of the Underwriters shall have discovered and disclosed to the Company on or prior to such Closing Date
that the Registration Statement or any amendment or supplement thereto contains an untrue statement of a fact which, in the opinion of
counsel for the Underwriters, is material or omits to state any fact which, in the opinion of such counsel, is material and is required
to be stated therein or is necessary to make the statements therein not misleading, or that the General Disclosure Package, any Issuer
Free Writing Prospectus or the Prospectus or any amendment or supplement thereto contains an untrue statement of fact which, in the opinion
of such counsel, is material or omits to state any fact which, in the opinion of such counsel, is material and is necessary in order to
make the statements, in the light of the circumstances in which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(b) <FONT STYLE="font-size: 10pt"><U>Corporate
Proceedings</U>. All corporate proceedings incident to the authorization, form and validity of each of this Agreement, the Shares, the
Registration Statement, the General Disclosure Package, each Issuer Free Writing Prospectus and the Prospectus and the transactions contemplated
hereby shall be reasonably satisfactory in all material respects to counsel for the Underwriters, and the Company shall have furnished
to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(c) <FONT STYLE="font-size: 10pt"><U>Opinion
and 10b-5 Statement of U.S. Counsel for the Company</U>. Paul Hastings LLP, US counsel for the Company, shall have furnished to the Representatives
such counsel&rsquo;s written opinion and 10b-5 Statement, as counsel to the Company, addressed to the Underwriters and dated such Closing
Date, in form and substance reasonably satisfactory to the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(d) <FONT STYLE="font-size: 10pt"><U>Opinion
of Israeli Counsel for the Company</U><I>. </I>Goldfarb Gross Seligman &amp; Co., Israeli counsel for the Company, shall have furnished
to the Representatives such counsel&rsquo;s written opinion, as counsel to the Company, addressed to the Underwriters and dated such Closing
Date, in form and substance reasonably satisfactory to the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(e) <FONT STYLE="font-size: 10pt"><U>Opinion
and 10b-5 Statement of Counsel for the Underwriters.</U> The Representatives shall have received from DLA Piper LLP (US), U.S. counsel
for the Underwriters, such opinion or opinions and 10b-5 Statement, dated such Closing Date, with respect to such matters as the Underwriters
may reasonably require, and the Company shall have furnished to such counsel such documents as they request for enabling them to pass
upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(f) <FONT STYLE="font-size: 10pt"><U>Comfort
Letter</U>. At the time of the execution of this Agreement, the Representatives shall have received from Kost Forer Gabbay &amp; Kasierer,
a member of EY Global, a letter, addressed to the Underwriters, executed and dated such date, in form and substance satisfactory to the
Representatives (i) confirming that they are an independent registered accounting firm with respect to the Company and its subsidiaries
within the meaning of the Securities Act and the Rules and Regulations and PCAOB and (ii) stating the conclusions and findings of such
firm, of the type ordinarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters, with respect to the financial
statements and certain financial information contained or incorporated by reference in the Registration Statement, the General Disclosure
Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(g) <FONT STYLE="font-size: 10pt"><U>Bring
Down Comfort</U>. On the effective date of any post-effective amendment to the Registration Statement and on such Closing Date, the
Representatives shall have received a letter (the &ldquo;<B><I>bring-down letter</I></B>&rdquo;) from Kost Forer Gabbay &amp;
Kasierer, a member of EY Global, addressed to the Underwriters and dated such Closing Date confirming, as of the date of the
bring-down letter (or, with respect to matters involving changes or developments since the respective dates as of which specified
financial information is given in the General Disclosure Package and the Prospectus, as the case may be, as of a date not more than
three (3) business days prior to the date of the bring-down letter), the conclusions and findings of such firm, of the type
ordinarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters, with respect to the financial information
and other matters covered by its letter delivered to the Representatives concurrently with the execution of this Agreement pursuant
to paragraph (i) of this Section 6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(h) <FONT STYLE="font-size: 10pt"><U>Officer&rsquo;s
Certificate</U>. The Company shall have furnished to the Representatives a certificate, dated such Closing Date, of its Chairman of the
Board or Chief Executive Officer and its Chief Financial Officer stating in their respective capacities as officers of the Company on
behalf of the Company that (i) no stop order suspending the effectiveness of the Registration Statement (including, for avoidance of doubt,
any Rule 462(b) Registration Statement), or any post-effective amendment thereto, shall be in effect and no proceedings for such purpose
shall have been instituted or, to their knowledge, threatened by the Commission, (ii) for the period from and including the date of this
Agreement through and including such Closing Date, there has not occurred any Material Adverse Effect, (iii) to their knowledge, after
reasonable investigation, as of such Closing Date, the representations and warranties of the Company in this Agreement are true and correct
and the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or
prior to such Closing Date, and (iv) there has not been, subsequent to the date of the most recent audited financial statements included
or incorporated by reference in the General Disclosure Package, any Material Adverse Effect in the financial position or results of operations
of the Company, or any change or development that, singularly or in the aggregate, would reasonably be expected to involve a Material
Adverse Effect, except as set forth in the General Disclosure Package and the Prospectus. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(i) <FONT STYLE="font-size: 10pt"><U>No
Material Adverse Effect</U>. Since the date of the latest audited financial statements included in the General Disclosure Package or
incorporated by reference in the General Disclosure Package as of the date hereof, (i) neither the Company nor any of its
subsidiaries shall have sustained any loss or interference with its business from fire, explosion, flood or other calamity, whether
or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth
in the General Disclosure Package, and (ii) there shall not have been any change in the share capital or long-term debt of the
Company or any of its subsidiaries, or any change, or any development involving a prospective change, in or affecting the business,
general affairs, management, financial position, shareholders&rsquo; equity or results of operations of the Company and its
subsidiaries, otherwise than as set forth in the General Disclosure Package, the effect of which, in any such case described in
clause (i) or (ii) of this paragraph (l), is, in the judgment of the Representatives, so material and adverse as to make it
impracticable or inadvisable to proceed with the sale or delivery of the Shares on the terms and in the manner contemplated in the
General Disclosure Package.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(j) <FONT STYLE="font-size: 10pt"><U>No
Legal Impediment to Issuance</U>. No action shall have been taken and no law, statute, rule, regulation or order shall have been enacted,
adopted or issued by any governmental or regulatory agency or body which would prevent the issuance or sale of the Shares; and no injunction,
restraining order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued which would
prevent the issuance or sale of the Shares or materially and adversely affect or potentially materially and adversely affect the business
or operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(k) <FONT STYLE="font-size: 10pt"><U>No
Downgrade</U>. Subsequent to the execution and delivery of this Agreement (i) no downgrading shall have occurred in the Company&rsquo;s
corporate credit rating or the rating accorded the Company&rsquo;s debt securities by any &ldquo;nationally recognized statistical rating
organization,&rdquo; as that term is defined by the Commission for purposes of Rule 436(g)(2) of the Rules and Regulations and (ii) no
such organization shall have publicly announced that it has under surveillance or review (other than an announcement with positive implications
of a possible upgrading), the Company&rsquo;s corporate credit rating or the rating of any of the Company&rsquo;s debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(l) <FONT STYLE="font-size: 10pt"><U>Market
Conditions</U>. Subsequent to the execution and delivery of this Agreement there shall not have occurred any of the following: (i) trading
in any of the Company&rsquo;s securities shall have been suspended or materially limited by the Commission or an Exchange, or trading
in securities generally on the New York Stock Exchange, Nasdaq Global Select Market, Nasdaq Global Market, Nasdaq Capital Market, the
NYSE MKT LLC, the TASE, or in the over-the-counter market, or trading in any securities of the Company on any exchange or in the over-the-counter
market, shall have been suspended or materially limited, or minimum or maximum prices or maximum range for prices shall have been established
on any such exchange or such market by the Commission, by such exchange or market or by any other regulatory body or governmental authority
having jurisdiction, (ii) a banking moratorium shall have been declared by Federal, state or Israeli authorities or a material disruption
has occurred in commercial banking or securities settlement or clearance services in the United States or Israel, (iii) the United States
shall have become engaged in hostilities, or the subject of an act of terrorism, or there shall have been an outbreak of or escalation
in hostilities involving the United States, or there shall have been a declaration of a national emergency or war by the United States
or (iv) there shall have occurred such a material adverse change in general economic, political or financial conditions (or the effect
of international conditions on the financial markets in the United States shall be such) as to make it, in the judgment of the Representatives,
impracticable or inadvisable to proceed with the sale or delivery of the Shares on the terms and in the manner contemplated in the General
Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(m) <FONT STYLE="font-size: 10pt"><U>Exchange
Listing</U>. Prior to the first Closing Date, the Company shall have submitted a Notification: Listing of Additional Shares with the Nasdaq
Stock Market. In addition, prior to the first Closing Date, the Shares shall have been approved in principle for listing on the TASE by
the TASE, subject only to official notice of issuance, and the Underwriters or their counsel shall have received, on or prior to such
date, a copy of such approval in principle of the TASE for the listing for trade of the Shares, which approval (or a final approval issued
by the TASE for the listing of the such Shares) shall be in full force and effect on each Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(n) <FONT STYLE="font-size: 10pt"><U>Good
Standing</U>. The Representatives shall have received on and as of such Closing Date satisfactory evidence of the good standing of the
Company and its subsidiaries in their respective jurisdictions of organization and their good standing as foreign entities in such other
jurisdictions as the Representatives may reasonably request, in each case in writing or any standard form of telecommunication from the
appropriate governmental authorities of such jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(o) <FONT STYLE="font-size: 10pt"><U>Lock
Up Agreements</U>. The Representatives shall have received the written agreements, substantially in the form of <U>Exhibit&nbsp;I</U>
hereto, of the officers, directors, shareholders, optionholders and warrantholders of the Company listed in <U>Schedule D</U> to this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(p) <FONT STYLE="font-size: 10pt"><U>Secretary&rsquo;s
Certificate</U>. The Company shall have furnished to the Representatives a Secretary&rsquo;s Certificate of the Company, in form and substance
reasonably satisfactory to counsel for the Underwriters and customary for the type of offering contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(q) <FONT STYLE="font-size: 10pt"><U>Additional
Documents</U>. On or prior to such Closing Date, the Company shall have furnished to the Representatives such further certificates and
documents as the Representatives may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All opinions, letters, evidence
and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if
they are in form and substance reasonably satisfactory to counsel for the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">7. <I>Indemnification
and Contribution.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(a) <FONT STYLE="font-size: 10pt"><U>Indemnification
of Underwriters by the Company</U>. The Company shall indemnify and hold harmless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">each Underwriter, its affiliates, directors,
officers, managers, members, employees, representatives and agents and each person, if any, who controls any Underwriter within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively the &ldquo;<B><I>Underwriter Indemnified Parties</I></B>,&rdquo;
and each an &ldquo;<B><I>Underwriter Indemnified Party</I></B>&rdquo;) against any loss, claim, damage, expense or liability whatsoever
(or any action, investigation or proceeding in respect thereof), joint or several, to which such Underwriter Indemnified Party may become
subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, expense, liability, action, investigation or proceeding
arises out of or is based upon (A) any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus,
any Issuer Free Writing Prospectus, any &ldquo;issuer information&rdquo; filed or required to be filed pursuant to Rule 433(d) of the
Rules and Regulations, the Registration Statement, the Prospectus, or in any amendment or supplement thereto or document incorporated
by reference therein or in any materials or information provided to investors by, or with the approval of, the Company in connection with
the marketing of the offering of the Shares, including any roadshow or investor presentations made to investors by the Company (whether
in person or electronically) (&ldquo;<B><I>Marketing Materials</I></B>&rdquo;) or (B) the omission or alleged omission to state in any
Preliminary Prospectus, any Issuer Free Writing Prospectus, any &ldquo;issuer information&rdquo; filed or required to be filed pursuant
to Rule 433(d) of the Rules and Regulations, the Registration Statement or the Prospectus, or in any amendment or supplement thereto or
document incorporated by reference therein, or in any Marketing Materials, a material fact required to be stated therein or necessary
to make the statements therein not misleading, and shall reimburse each Underwriter Indemnified Party promptly upon demand for any legal
fees or other expenses reasonably incurred by that Underwriter Indemnified Party in connection with investigating, or preparing to defend,
or defending against, or appearing as a third party witness in respect of, or otherwise incurred in connection with, any such loss, claim,
damage, expense, liability, action, investigation or proceeding, as such fees and expenses are incurred; <I>provided</I>, <I>however</I>,
that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, expense or liability arises out
of or is based upon an untrue statement or alleged untrue statement in, or omission or alleged omission from any Preliminary Prospectus,
the Registration Statement or the Prospectus, or any such amendment or supplement thereto, any Issuer Free Writing Prospectus or any Marketing
Materials made in reliance upon and in conformity with written information furnished to the Company through the Representatives by or
on behalf of any Underwriter specifically for use therein, which information the parties hereto agree is limited to the Underwriters&rsquo;
Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Each indemnity agreement in this Section
7(a) is not exclusive and is in addition to each other indemnity agreement in this Section 7(a) and each other liability which the Company
might have under this Agreement or otherwise, and shall not limit any rights or remedies which may otherwise be available under this Agreement,
at law or in equity to any Underwriter Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(b) <FONT STYLE="font-size: 10pt"><U>Indemnification
of Company by the Underwriters</U>. Each Underwriter, severally and not jointly, shall indemnify and hold harmless the Company and its
directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively the &ldquo;<B>Company Indemnified Parties</B>&rdquo;
and each a &ldquo;<B><I>Company Indemnified Party</I></B>&rdquo;) against any loss, claim, damage, expense or liability whatsoever (or
any action, investigation or proceeding in respect thereof), joint or several, to which such Company Indemnified Party may become subject,
under the Securities Act or otherwise, insofar as such loss, claim, damage, expense, liability, action, investigation or proceeding arises
out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus,
any Issuer Free Writing Prospectus, any &ldquo;issuer information&rdquo; filed or required to be filed pursuant to Rule 433(d) of the
Rules and Regulations, the Registration Statement or the Prospectus, or in any amendment or supplement thereto, or (ii) the omission or
alleged omission to state in any Preliminary Prospectus, any Issuer Free Writing Prospectus, any &ldquo;issuer information&rdquo; filed
or required to be filed pursuant to Rule 433(d) of the Rules and Regulations, the Registration Statement or the Prospectus, or in any
amendment or supplement thereto, a material fact required to be stated therein or necessary to make the statements therein not misleading,
but in each case only to the extent that the untrue statement or alleged untrue statement or omission or alleged omission was made in
reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of that
Underwriter specifically for use therein, which information the parties hereto agree is limited to the Underwriters&rsquo; Information,
and shall reimburse the Company Indemnified Parties for any legal or other expenses reasonably incurred by such party in connection with
investigating or preparing to defend or defending against or appearing as third party witness in connection with any such loss, claim,
damage, liability, action, investigation or proceeding, as such fees and expenses are incurred. This indemnity agreement is not exclusive
and will be in addition to any liability which the Underwriters might otherwise have and shall not limit any rights or remedies which
may otherwise be available under this Agreement, at law or in equity to the Company Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Promptly
after receipt by an indemnified party under this Section 7 of notice of the commencement of any action, the indemnified party shall, if
a claim in respect thereof is to be made against an indemnifying party under this Section 7, notify such indemnifying party in writing
of the commencement of that action; <I>provided, however</I>, that the failure to notify the indemnifying party shall not relieve it from
any liability which it may have under this Section 7 except to the extent it has been materially prejudiced by such failure; and, <I>provided,
further</I>, that the failure to notify an indemnifying party shall not relieve it from any liability which it may have to an indemnified
party otherwise than under this Section 7. If any such action shall be brought against an indemnified party, and it shall notify the indemnifying
party thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other
similarly notified indemnifying party, to assume the defense of such action with counsel reasonably satisfactory to the indemnified party
(which counsel shall not, except with the written consent of the indemnified party, be counsel to the indemnifying party). After notice
from the indemnifying party to the indemnified party of its election to assume the defense of such action, except as provided herein,
the indemnifying party shall not be liable to the indemnified party under Section 7 for any legal or other expenses subsequently incurred
by the indemnified party in connection with the defense of such action other than reasonable costs of investigation; <I>provided, however</I>,
that any indemnified party shall have the right to employ separate counsel in any such action and to participate in the defense of such
action but the fees and expenses of such counsel (other than reasonable costs of investigation) shall be at the expense of such indemnified
party unless (i) the employment thereof has been specifically authorized in writing by the Company in the case of a claim for indemnification
under Section 7(a) or the Representatives in the case of a claim for indemnification under Section 7(b), (ii) such indemnified party shall
have been advised by its counsel that there may be one or more legal defenses available to it which are different from or additional to
those available to the indemnifying party, or (iii) the indemnifying party has failed to assume the defense of such action and employ
counsel reasonably satisfactory to the indemnified party within a reasonable period of time after notice of the commencement of the action
or the indemnifying party does not diligently defend the action after assumption of the defense, in which case, if such indemnified party
notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the indemnifying party, the indemnifying
party shall not have the right to assume the defense of (or, in the case of a failure to diligently defend the action after assumption
of the defense, to continue to defend) such action on behalf of such indemnified party and the indemnifying party shall be responsible
for legal or other expenses subsequently incurred by such indemnified party in connection with the defense of such action; <I>provided</I>,
<I>however</I>, that, the indemnifying party shall not, in connection with any one such action or separate but substantially similar or
related actions in the same jurisdiction arising out of the same general allegations or circumstances, be liable for the reasonable fees
and expenses of more than one separate firm of attorneys at any time for all such indemnified parties (in addition to any local counsel),
which firm shall be designated in writing by the Representatives if the indemnified parties under this Section 7 consist of any Underwriter
Indemnified Party or by the Company if the indemnified parties under this Section&nbsp;7 consist of any Company Indemnified Parties. Subject
to this Section 7(c), the amount payable by an indemnifying party under Section 7 shall include, but not be limited to, (x) reasonable
legal fees and expenses of counsel to the indemnified party and any other expenses in investigating, or preparing to defend or defending
against, or appearing as a third party witness in respect of, or otherwise incurred in connection with, any action, investigation, proceeding
or claim, and (y) all amounts paid in settlement of any of the foregoing. No indemnifying party shall, without the prior written consent
of the indemnified parties, settle or compromise or consent to the entry of judgment with respect to any pending or threatened action
or any claim whatsoever, in respect of which indemnification or contribution could be sought under this Section 7 (whether or not the
indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional
release of each indemnified party in form and substance reasonably satisfactory to such indemnified party from all liability arising out
of such action or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on
behalf of any indemnified party. Subject to the provisions of the following sentence, no indemnifying party shall be liable for settlement
of any pending or threatened action or any claim whatsoever that is effected without its written consent, but if settled with its written
consent or if there be a judgment for the plaintiff in any such matter, the indemnifying party agrees to indemnify and hold harmless any
indemnified party from and against any loss or liability by reason of such settlement or judgment. In addition, if at any time an indemnified
party shall have requested that an indemnifying party reimburse the indemnified party for fees and expenses of counsel, such indemnifying
party agrees that it shall be liable for any settlement of the nature contemplated by Section 7(a) effected without its written consent
if (i) such settlement is entered into more than forty-five (45) days after receipt by such indemnifying party of the request for reimbursement,
(ii) such indemnifying party shall have received notice of the terms of such settlement at least thirty (30) days prior to such settlement
being entered into and (iii)&nbsp;such indemnifying party shall not have reimbursed such indemnified party in accordance with such request
prior to the date of such settlement.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(d) <FONT STYLE="font-size: 10pt">If
the indemnification provided for in this Section 7 is unavailable or insufficient to hold harmless an indemnified party under
Section 7(a) or 7(b), then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount
paid, payable or otherwise incurred by such indemnified party as a result of such loss, claim, damage, expense or liability (or any
action, investigation or proceeding in respect thereof), as incurred, (i) in such proportion as shall be appropriate to reflect the
relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Shares, or (ii)
if the allocation provided by clause (i) of this Section 7(d) is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i) of this Section 7(d) but also the relative fault of
the Company on the one hand and the Underwriters on the other with respect to the statements, omissions, acts or failures to act
which resulted in such loss, claim, damage, expense or liability (or any action, investigation or proceeding in respect thereof) as
well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the
Underwriters on the other with respect to such offering shall be deemed to be in the same proportion as the total net proceeds from
the offering of the Shares purchased under this Agreement (before deducting expenses) received by the Company bear to the total
underwriting discounts and commissions received by the Underwriters with respect to the Shares purchased under this Agreement, in
each case as set forth in the table on the cover page of the Prospectus. The relative fault of the Company on the one hand and the
Underwriters on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of
a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the
one hand or the Underwriters on the other, the intent of the parties and their relative knowledge, access to information and
opportunity to correct or prevent such untrue statement, omission, act or failure to act; <I>provided</I> that the parties hereto
agree that the written information furnished to the Company through the Representatives by or on behalf of the Underwriters for use
in the Preliminary Prospectus, the Registration Statement or the Prospectus, or in any amendment or supplement thereto, consists
solely of the Underwriters&rsquo; Information. </FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(e) <FONT STYLE="font-size: 10pt">The
Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to Section 7(d) above were to be
determined by pro rata allocation or by any other method of allocation which does not take into account the equitable considerations referred
to Section 7(d) above. The amount paid or payable by an indemnified party as a result of the loss, claim, damage, expense, liability,
action, investigation or proceeding referred to in Section 7(d) above shall be deemed to include, subject to the limitations set forth
above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating, preparing to defend
or defending against or appearing as a third party witness in respect of, or otherwise incurred in connection with, any such loss, claim,
damage, expense, liability, action, investigation or proceeding. Notwithstanding the provisions of this Section 7, no Underwriters shall
be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such
Underwriter with respect to the offering of the Shares exceeds the amount of any damages which the Underwriter has otherwise paid or become
liable to pay by reason of any untrue or alleged untrue statement, omission or alleged omission, act or alleged act or failure to act
or alleged failure to act. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&rsquo; obligations
to contribute as provided in this Section 7 are several in proportion to their respective underwriting obligations and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">8. <I>Termination</I>.</FONT>
The obligations of the Underwriters hereunder may be terminated by the Representatives, in their absolute discretion by notice given to
the Company prior to delivery of and payment for the Firm Shares if, prior to that time, any of the events described in Sections 6(i),
6(k) or 6(l) have occurred or if the Underwriters shall decline to purchase the Shares for any reason permitted under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">9. <I>Reimbursement
of Underwriters&rsquo; Expenses</I></FONT>. Notwithstanding anything to the contrary in this Agreement, if (a) this Agreement shall have
been terminated pursuant to Section 8 or 10, (b) the Company shall fail to tender the Shares for delivery to the Underwriters for any
reason not permitted under this Agreement, (c) the Underwriters shall decline to purchase the Shares for any reason permitted under this
Agreement or (d) the sale of the Shares is not consummated because any condition to the obligations of the Underwriters set forth herein
is not satisfied or because of the refusal, inability or failure on the part of the Company to perform any agreement herein or to satisfy
any condition or to comply with the provisions hereof, then in addition to the payment of amounts in accordance with Section 5, the Company
shall reimburse the Underwriters for the fees and expenses of Underwriters&rsquo; counsel and for such other out-of-pocket expenses as
shall have been reasonably incurred by them in connection with this Agreement and the proposed purchase of the Shares, including, without
limitation, travel and lodging expenses of the Underwriters, and upon demand the Company shall pay the full amount thereof to the Representatives;
<I>provided</I> that if this Agreement is terminated pursuant to Section 10 by reason of the default of one or more Underwriters, the
Company shall not be obligated to reimburse any defaulting Underwriter on account of expenses to the extent incurred by such defaulting
Underwriter, <I>provided further</I> that the foregoing shall not limit any reimbursement obligation of the Company to any non-defaulting
Underwriter under this Section 9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">10. <I>Substitution
of Underwriters</I></FONT>. If any Underwriter or Underwriters shall default in its or their obligations to purchase Shares hereunder
on any Closing Date and the aggregate number of Shares which such defaulting Underwriter or Underwriters agreed but failed to purchase
does not exceed ten percent (10%) of the total number of Shares to be purchased by all Underwriters on such Closing Date, the other Underwriters
shall be obligated severally, in proportion to their respective commitments hereunder, to purchase the Shares which such defaulting Underwriter
or Underwriters agreed but failed to purchase on such Closing Date. If any Underwriter or Underwriters shall so default and the aggregate
number of Shares with respect to which such default or defaults occur is more than ten percent (10%) of the total number of Shares to
be purchased by all Underwriters on such Closing Date and arrangements satisfactory to the Representatives and the Company for the purchase
of such Shares by other persons are not made within forty-eight (48) hours after such default, this Agreement shall terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the remaining Underwriters
or substituted Underwriters are required hereby or agree to take up all or part of the Shares of a defaulting Underwriter or Underwriters
on such Closing Date as provided in this Section&nbsp;10, (i) the Company shall have the right to postpone such Closing Date for a period
of not more than five (5) full business days in order that the Company may effect whatever changes may thereby be made necessary in the
Registration Statement or the Prospectus, or in any other documents or arrangements, and the Company agrees promptly to file any amendments
to the Registration Statement or supplements to the Prospectus which may thereby be made necessary, and (ii) the respective numbers of
shares to be purchased by the remaining Underwriters or substituted Underwriters shall be taken as the basis of their underwriting obligation
for all purposes of this Agreement. Nothing herein contained shall relieve any defaulting Underwriter of its liability to the Company
or the other Underwriters for damages occasioned by its default hereunder. Any termination of this Agreement pursuant to this Section
10 shall be without liability on the part of any non-defaulting Underwriter or the Company, except that the representations, warranties,
covenants, indemnities, agreements and other statements set forth in Section 2, the obligations with respect to expenses to be paid or
reimbursed pursuant to Sections 5 and 9 and the provisions of Section 7 and Sections 11 through 22, inclusive, shall not terminate and
shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">11. <I>Absence
of Fiduciary Relationship. </I></FONT> The Company acknowledges and agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(a)  each
Underwriter&rsquo;s responsibility to the Company is solely contractual in nature, the Representatives have been retained solely to act
as underwriters in connection with the sale of the Shares and no fiduciary, advisory or agency relationship between the Company and the
Representatives has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether any of
the Underwriters has advised or is advising the Company on other matters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(b)  the
price of the Shares set forth in this Agreement was established by the Company following discussions and arms-length negotiations with
the Representatives, and the Company is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions
of the transactions contemplated by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(c)  it
has been advised that the Representatives and their affiliates are engaged in a broad range of transactions which may involve interests
that differ from those of the Company and that the Representatives have no obligation to disclose such interests and transactions to the
Company by virtue of any fiduciary, advisory or agency relationship; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(d)  it
waives, to the fullest extent permitted by law, any claims it may have against the Underwriters for breach of fiduciary duty or alleged
breach of fiduciary duty and agrees that the Underwriters shall have no liability (whether direct or indirect) to the Company in respect
of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company, including shareholders,
employees or creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">12. <I>Successors;
Persons Entitled to Benefit of Agreement</I></FONT>. This Agreement shall inure to the benefit of and be binding upon the several Underwriters,
the Company and their respective successors and assigns. Nothing expressed or mentioned in this Agreement is intended or shall be construed
to give any person, other than the persons mentioned in the preceding sentence, any legal or equitable right, remedy or claim under or
in respect of this Agreement, or any provisions herein contained, this Agreement and all conditions and provisions hereof being intended
to be and being for the sole and exclusive benefit of such persons and for the benefit of no other person; except that the representations,
warranties, covenants, agreements and indemnities of the Company contained in this Agreement shall also be for the benefit of the Underwriter
Indemnified Parties, and the indemnities of the several Underwriters shall be for the benefit of the Company Indemnified Parties. It is
understood that each Underwriter&rsquo;s responsibility to the Company is solely contractual in nature and the Underwriters do not owe
the Company, or any other party, any fiduciary duty as a result of this Agreement. No purchaser of any of the Shares from any Underwriter
shall be deemed to be a successor or assign by reason merely of such purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">13. <I>Survival
of Indemnities, Representations, Warranties, etc</I></FONT><I>. </I> The respective indemnities, covenants, agreements, representations,
warranties and other statements of the Company and the several Underwriters, as set forth in this Agreement or made by them respectively,
pursuant to this Agreement, shall remain in full force and effect, regardless of any investigation made by or on behalf of any Underwriter,
the Company or any person controlling any of them and shall survive delivery of and payment for the Shares. Notwithstanding any termination
of this Agreement, including without limitation any termination pursuant to Section 8 or Section 10, the indemnities, covenants, agreements,
representations, warranties and other statements forth in Sections 2, 5, 7 and 9 and Sections 11 through 22, inclusive, of this Agreement
shall not terminate and shall remain in full force and effect at all times.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14. <I>Recognition of the U.S. Special Resolution
Regimes</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(a) <FONT STYLE="font-size: 10pt">In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were
governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(b) <FONT STYLE="font-size: 10pt">In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">15. <I>Notices</I></FONT>.
All statements, requests, notices and agreements hereunder shall be in writing, and:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">if to the Underwriters, shall be delivered
or sent by mail, telex, facsimile transmission or email to (i) TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, New York 10017,
Attention: Head of Equity Capital Markets, with a copy to CIBLegal@tdsecurities.com; and
(ii) William Blair &amp; Company, L.L.C., 150 North Riverside Plaza, Chicago, IL 60606, Attention: General Counsel, Facsimile: (312) 551-4646;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">if to
the Company shall be delivered or sent by mail, telex or email to Allot Ltd., 22 Hangar Street, Neve Ne&rsquo;eman Industrial Zone B,
Hod-Hasharon 45240, Israel, Attention: Rael Kolevsohn, Vice President of Legal Affairs, General Counsel, Company Secretary, Phone: </FONT>[***]<FONT STYLE="font-size: 10pt">,
email: [***];</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>provided, however,</I> that any notice to
an Underwriter pursuant to Section 7 shall be delivered or sent by mail, or facsimile transmission to such Underwriter at its address
set forth in its acceptance telex to the Representatives, which address will be supplied to any other party hereto by the Representatives
upon request. Any such statements, requests, notices or agreements shall take effect at the time of receipt thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">16. <I>Definition
of Certain Terms</I></FONT>. For purposes of this Agreement, (a) &ldquo;<B><I>affiliate</I></B>&rdquo; has the meaning set forth in Rule
405 under the Securities Act, (b) &ldquo;<B><I>business day</I></B>&rdquo; means any day on which the New York Stock Exchange, Inc. is
open for trading, (c) &ldquo;<B><I>subsidiary</I></B>&rdquo; has the meaning set forth in Rule&nbsp;405 of the Rules and Regulations;
(d) &ldquo;<B><I>BHC Act Affiliate</I></B>&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted
in accordance with, 12 U.S.C. &sect; 1841(k), (e) &ldquo;<B><I>Covered Entity</I></B>&rdquo; means any of the following: (i) a &ldquo;covered
entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect;&nbsp;252.82(b); (ii) a &ldquo;covered bank&rdquo;
as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect;&nbsp;47.3(b); or (iii) a &ldquo;covered FSI&rdquo; as
that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect;&nbsp;382.2(b), (f) &ldquo;<B><I>Default Right</I></B>&rdquo;
has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as
applicable, (g) &ldquo;<B><I>U.S. Special Resolution Regime</I></B>&rdquo; means each of (i) the Federal Deposit Insurance Act and the
regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations
promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">17. <I>Judgement
Currency. </I></FONT>The obligations of the Company pursuant to this Agreement in respect of any sum due to any Underwriter shall, notwithstanding
any judgment in a currency other than United States dollars, not be discharged until the first business day, following receipt by such
Underwriter of any sum adjudged to be so due in such other currency, on which (and only to the extent that) such Underwriter may in accordance
with normal banking procedures purchase United States dollars with such other currency; if the United States dollars so purchased are
less than the sum originally due to such Underwriter hereunder, the Company agrees, as a separate obligation and notwithstanding any such
judgment, to indemnify such Underwriter against such loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">18. <I>Governing Law, Jurisdiction,
Waiver of Jury Trial, Agent For Service.</I></FONT> This Agreement shall be governed by and construed in accordance with the laws of the
State of New York, including without limitation Section 5-1401 of the New York General Obligations. The Company irrevocably (a) submits
to the exclusive jurisdiction of the Federal and state courts in the Borough of Manhattan in The City of New York for the purpose of any
suit, action or other proceeding arising out of this Agreement or the transactions contemplated by this Agreement, the Registration Statement
and any Preliminary Prospectus or the Prospectus, (b) agrees that all claims in respect of any such suit, action or proceeding may be
heard and determined by any such court, (c) waives to the fullest extent permitted by applicable law, any immunity from the jurisdiction
of any such court or from any legal process, (d) agrees not to commence any such suit, action or proceeding other than in such courts,
and (e) waives, to the fullest extent permitted by applicable law, any claim that any such suit, action or proceeding is brought in an
inconvenient forum. <B>Each of the parties to this Agreement hereby waives any right to trial by jury in any suit or proceeding arising
out of or relating to this Agreement.</B> The Company irrevocably appoints Allot Communications, Inc., with offices at 1500 District Avenue,
Burlington, MA 01803 <I>(</I>and its successors) as its authorized agent in the Borough of Manhattan in The City of New York upon which
process may be served in any such suit or proceeding, and agrees that service of process upon such agent, and written notice of said service
to the Company by the person serving the same to the address provided in Section 15, shall be deemed in every respect effective service
of process upon the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">19. <I>Underwriters&rsquo;
Information</I></FONT><I>.</I> The parties hereto acknowledge and agree that, for all purposes of this Agreement, the Underwriters&rsquo;
Information consists solely of the following information in the Prospectus: the statements concerning the Underwriters contained in the
second sentence of the eighth paragraph, the ninth paragraph and the first sentence of the tenth paragraph under the heading &ldquo;<I>Underwritin</I>g.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">20. <I>Authority
of the Representatives</I></FONT>. In connection with this Agreement, the Representatives will act for and on behalf of the several Underwriters,
and any action taken under this Agreement by the Representatives will be binding on all the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">21. <I>Partial
Unenforceability</I>. </FONT>The invalidity or unenforceability of any section, paragraph, clause or provision of this Agreement shall
not affect the validity or enforceability of any other section, paragraph, clause or provision hereof. If any section, paragraph, clause
or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor
changes (and only such minor changes) as are necessary to make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">22. <I>General</I></FONT>.
This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof. In this Agreement, the masculine, feminine
and neuter genders and the singular and the plural include one another. The section headings in this Agreement are for the convenience
of the parties only and will not affect the construction or interpretation of this Agreement. This Agreement may be amended or modified,
and the observance of any term of this Agreement may be waived, only by a writing signed by the Company and the Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">23. <I>Counterparts</I></FONT>.
This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument. This Agreement may be delivered via facsimile, electronic mail (including pdf or any
electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com or www.echosign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing is in accordance
with your understanding please indicate your acceptance of this Agreement by signing in the space provided for that purpose below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">ALLOT LTD.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"> /s/ Eyal Harari</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 32%"> Eyal Harari</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Accepted as of</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>the date first above written:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: normal small-caps 10pt Times New Roman, Times, Serif">TD Securities (USA) LLC</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-variant: small-caps">William Blair &amp; Company, L.L.C.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in">Acting on their own behalf</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in">and as Representatives of several</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in">Underwriters listed on <U>Schedule A</U> to this <BR>
Agreement.</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="font: normal small-caps 10pt Times New Roman, Times, Serif">TD Securities (USA) LLC</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ Vinni Trehan</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 32%"> Vinni Trehan</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD> Managing Director</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="font: normal small-caps 10pt Times New Roman, Times, Serif">William Blair &amp; Company, L.L.C.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ Steve Maletzky</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Steve Maletzky</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD> Head of Capital Markets</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SCHEDULE A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Firm <BR> Shares<BR> to be <BR> Purchased</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Optional Shares<BR> to be <BR> Purchased</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">TD Securities (USA) LLC</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,900,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">285,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">William Blair &amp; Company, L.L.C.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,900,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Needham &amp; Company, LLC</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">850,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">127,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Northland Securities, Inc.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">350,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">52,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt; padding-left: 0.125in">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,000,000</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">750,000</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">General Use Free Writing Prospectuses</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE C</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">Pricing Information</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Firm Shares to be Sold: 5,000,000 Ordinary Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Public Offering Price: $8.00 per share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Underwriting Discounts and Commissions: 5.5%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Estimated Net Proceeds to the Company (after underwriting
discounts and commissions, but before transaction expenses): $37,800,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE D</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>[Lock-Up Parties]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit I</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Lock-Up Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">June &nbsp;&nbsp;&nbsp;, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">TD Securities
(USA) LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">William
Blair &amp; Company, L.L.C.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As Representatives of the several Underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o TD Securities (USA) LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1 Vanderbilt Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o William Blair &amp; Company, L.L.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">150 N. Riverside Plaza</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chicago, Illinois 60606</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify">Allot Ltd. &ndash; Registration Statement on Form F-3 for
Ordinary Shares</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Sirs and Madams:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">This letter agreement (&ldquo;Agreement&rdquo;)
is being delivered to you in connection with the proposed Underwriting Agreement (the &ldquo;Underwriting Agreement&rdquo;) between Allot
Ltd., a company organized under the laws of the State of Israel (the &ldquo;Company&rdquo;), and TD Securities (USA) LLC (&ldquo;TD Cowen&rdquo;)
and William Blair &amp; Company, L.L.C. (&ldquo;William Blair&rdquo;), as representatives (the &ldquo;Representatives&rdquo;) of a group
of underwriters (collectively, the &ldquo;Underwriters&rdquo;), to be named therein, relating to the proposed public offering of ordinary
shares, par value NIS 0.10 per share (the &ldquo;Ordinary Shares&rdquo;) of the Company (the &ldquo;Offering&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to induce the Underwriters to enter into
the Underwriting Agreement, and in light of the benefits that the Offering will confer upon the undersigned in his, her or its capacity
as a securityholder and/or an officer, director or employee of the Company, and for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the undersigned agrees with each Underwriter that, during the period beginning on the date hereof through
and including the date that is the 75<SUP>th</SUP> day after the date of the Underwriting Agreement (the &ldquo;Lock-Up Period&rdquo;),
the undersigned will not, and will not cause or direct any of its affiliates to, without the prior written consent of TD Cowen and William
Blair, directly or indirectly, (i) offer, sell, assign, transfer, pledge, contract to sell, lend or otherwise dispose of, or announce
the intention to otherwise dispose of, any Ordinary Shares (including, without limitation, Ordinary Shares which may be deemed to be beneficially
owned by the undersigned in accordance with the rules and regulations promulgated under the Securities Exchange Act of 1934, as amended
(the &ldquo;Exchange Act&rdquo;) as the same may be amended or supplemented from time to time (such shares, the &ldquo;Beneficially Owned
Shares&rdquo;)) or securities convertible into or exercisable or exchangeable for Ordinary Shares, (ii) enter into, or announce the intention
to enter into, any swap, hedge or similar agreement or arrangement (including, without limitation, the purchase or sale of, or entry into,
any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or
defined) that transfers, is designed to transfer or reasonably could be expected to transfer (whether by the undersigned or someone other
than the undersigned) in whole or in part, directly or indirectly, the economic risk of ownership of the Beneficially Owned Shares or
securities convertible into or exercisable or exchangeable for Ordinary Shares, whether now owned or hereafter acquired by the undersigned
or with respect to which the undersigned has or hereafter acquires the power of disposition (the &ldquo;Prohibited Activity&rdquo;), or
(iii) engage in, or announce the intention to engage in, any short selling of the Ordinary Shares or securities convertible into or exercisable
or exchangeable for Ordinary Shares. The undersigned represents and warrants that the undersigned is not, and has not caused or directed
any of its affiliates to be or become, currently a party to any agreement or arrangement that is designed to or which reasonably could
be expected to lead to or result in any Prohibited Activity during the Lock-Up Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the undersigned is not a natural person, the
undersigned represents and warrants that no single natural person, entity or &ldquo;group&rdquo; (within the meaning of Section 13(d)(3)
of the Exchange Act, other than a natural person, entity or &ldquo;group&rdquo; (as described above) that has executed an Agreement in
substantially the same form as this Agreement, beneficially owns, directly or indirectly, 50% or more of the common equity interests,
or 50% or more of the voting power, in the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The restrictions set forth in the preceding paragraphs
shall not apply to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(1) if
the undersigned is a natural person, any transfers made by the undersigned (a)&nbsp;as a bona fide gift to any member of the immediate
family (as defined below) of the undersigned or to a trust the beneficiaries of which are exclusively the undersigned or members of the
undersigned&rsquo;s immediate family, (b)&nbsp;by will or intestate succession upon the death of the undersigned or (c)&nbsp;as a bona
fide gift to a charity or educational institution;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(2) if
the undersigned is a corporation, partnership, limited liability company or other business entity, any transfers to any stockholder, partner
or member of, or owner of a similar equity interest in, the undersigned, as the case may be, if, in any such case, such transfer is not
for value;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(3) if
the undersigned is a corporation, partnership, limited liability company or other business entity, any transfer made by the undersigned
(a) in connection with the sale or other bona fide transfer in a single transaction of all or substantially all of the undersigned&rsquo;s
capital stock, partnership interests, membership interests or other similar equity interests, as the case may be, or all or substantially
all of the undersigned&rsquo;s assets, in any such case not undertaken for the purpose of avoiding the restrictions imposed by this Agreement
or (b) to another corporation, partnership, limited liability company or other business entity so long as the transferee is an affiliate
(as defined below) of the undersigned and such transfer is not for value;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(4) transactions
by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement or pursuant
to any court order or the order of any other governmental authority or agency having jurisdiction over the undersigned;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(5) transfers
to the Company from an employee of the Company upon death, disability or termination of employment (with or without cause) or resignation,
in each case, of such employee or to the Company from an employee pursuant to any contractual arrangement existing on the date hereof
that provides the Company with a right to purchase Ordinary Shares or other securities convertible into or exercisable or exchangeable
for Ordinary Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(6) transfers
to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (1) through (5) above;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(7) transfers
to the Company, in connection with any reclassification, exchange or conversion of Ordinary Shares, provided, that any such Ordinary Shares
received upon such reclassification, exchange or conversion shall be subject to the terms of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(8) transactions
relating to Ordinary Shares or other securities convertible into or exercisable or exchangeable for Ordinary Shares acquired in the Offering
or in open market transactions after completion of the Offering, provided that no such transaction is required to be, or is, publicly
announced (whether on Form 4, Form 5 or otherwise) during the Lock-Up Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(9) the
entry, by the undersigned, at any time on or after the date of the Underwriting Agreement, of any trading plan providing for the sale
of Ordinary Shares by the undersigned, which trading plan meets the requirements of Rule 10b5-1(c) (a &ldquo;10b5-1 Plan&rdquo;) under
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), provided, however, that such plan does not provide for,
or permit, the sale of any Ordinary Shares during the Lock-up Period and, except as required by applicable securities laws, no public
announcement or filing is voluntarily made or required regarding such plan during the Lock-Up Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(10)  any
transactions made for the purpose of satisfying any tax withholding obligations (including estimated taxes) pursuant to the Company&rsquo;s
equity incentive plans or arrangements disclosed in the Prospectus (as defined in the Underwriting Agreement); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(11) transfers
pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved by the Board of
Directors of the Company and made to all holders of the Company&rsquo;s share capital involving a Change of Control of the Company (for
purposes hereof, &ldquo;Change of Control&rdquo; shall mean the transfer (whether by tender offer, merger, consolidation or other similar
transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of share capital if,
after such transfer, such person or group of affiliated persons would hold at least a majority of the outstanding voting securities of
the Company (or the surviving entity)); provided that in the event that such transaction is not completed, the undersigned&rsquo;s Beneficially
Owned Shares shall remain subject to the provisions of this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">(12)  transactions
with the Company involving the amendment or repayment of any convertible debt security outstanding on the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">provided, however, that in the case of any transaction
described in clause (12) above, it being understood that any Ordinary Shares issued by the Company in connection with such amendment or
repayment will be subject to the restrictions of this Agreement; and, provided further, that in the case of any transfer described in
clause&nbsp;(1), (2), (3), (4) or (6)&nbsp;above, it shall be a condition to the transfer that (A)&nbsp;the transferee executes and delivers
to TD Cowen and William Blair, acting on behalf of the Underwriters, not later than one business day prior to such transfer, a written
agreement, in substantially the form of this Agreement (it being understood that any references to &ldquo;immediate family&rdquo; in the
agreement executed by such transferee shall expressly refer only to the immediate family of the undersigned and not to the immediate family
of the transferee) and otherwise satisfactory in form and substance to TD Cowen and William Blair, and (B) in the case of any transfer
described in clause (1), (2), (3), (4) or (10) above, no public announcement or filing is voluntarily made regarding such transfer during
the Lock-Up Period and if the undersigned is required to make a filing under Section&nbsp;16(a) or Section 13 of the Exchange Act, reporting
a reduction in beneficial ownership of Ordinary Shares or Beneficially Owned Shares or any securities convertible into or exercisable
or exchangeable for Ordinary Shares or Beneficially Owned Shares during the Lock-Up Period, the undersigned shall include a statement
in such filing to the effect that, (i) in the case of any transfer pursuant to clause&nbsp;(1) above, such transfer is being made as a
gift or by will or intestate succession, (ii) in the case of any transfer pursuant to clause&nbsp;(2) above, such transfer is being made
to a stockholder, partner or member of, or owner of a similar equity interest in, the undersigned and is not a transfer for value, (iii)
in the case of any transfer pursuant to clause (3) above, such transfer is being made either (a) in connection with the sale or other
bona fide transfer in a single transaction of all or substantially all of the undersigned&rsquo;s capital stock, partnership interests,
membership interests or other similar equity interests, as the case may be, or all or substantially all of the undersigned&rsquo;s assets
or (b) to another corporation, partnership, limited liability company or other business entity that is an affiliate of the undersigned
and such transfer is not for value, (iv) in the case of any transfer pursuant to clause (4) above, such transaction is made by operation
of law, and (v) in the case of any transfer pursuant to clause (10) above, such transfer is being made to satisfy tax withholding obligations.
For purposes of this paragraph, &ldquo;immediate family&rdquo; shall mean a spouse, child, grandchild or other lineal descendant (including
by adoption), father, mother, brother or sister of the undersigned; and &ldquo;affiliate&rdquo; shall have the meaning set forth in Rule
405 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a release from lockup restrictions
similar to those set forth herein is granted to any person pursuant to a similar agreement entered into in connection with the Offering,
the same percentage of the undersigned&rsquo;s Ordinary Shares (the &ldquo;Pro-rata Release&rdquo;) shall be immediately and fully released
on the same terms from any remaining lockup restrictions set forth herein. In the event that the undersigned is released from any of its
obligations under this Agreement or, by virtue of this Agreement, becomes entitled to offer, pledge, sell, contract to sell, or otherwise
dispose of any of the undersigned&rsquo;s Ordinary Shares prior to the termination of this Agreement, the Representatives shall use their
commercially reasonably efforts to provide notification of such to the undersigned within two (2) business days thereof, provided that
the failure to provide such notice shall not give rise to any claim or liability against the Representatives or the Underwriters. For
purposes of determining record or beneficial ownership of a stockholder, all securities held by investment funds affiliated with such
stockholder shall be aggregated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For avoidance of doubt, nothing in this Agreement
prohibits the undersigned from converting any convertible debt security into Ordinary Shares or exercising any options or warrants to
purchase Ordinary Shares (which exercises may be effected on a cashless basis to the extent the instruments representing such options
or warrants permit exercises on a cashless basis), it being understood that any Ordinary Shares issued upon such conversions or exercises
will be subject to the restrictions of this Agreement and provided, however, that no public announcement or filing is voluntarily made
regarding such conversion or exercise during the Lock-Up Period without the consent of the Representatives and provided that if the undersigned
is required to make a filing under Section 16(a) or Section 13 of the Exchange Act reporting a reduction in beneficial ownership of such
convertible debt securities, options or warrants during the Lock-Up Period, the undersigned shall include a statement in such filing to
the effect that the disposition relates to the conversion of a convertible debt security or exercise of an option or warrant, as applicable,
and that the Ordinary Shares received upon conversion or exercise are subject to the restrictions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to enable this covenant to be enforced,
the undersigned hereby consents to the placing of legends or stop transfer instructions with the Company&rsquo;s transfer agent with respect
to any Ordinary Shares or securities convertible into or exercisable or exchangeable for Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned further agrees that it will not,
during the Lock-Up Period, make any demand or request for or exercise any right with respect to the registration under the Securities
Act, of any Ordinary Shares or other Beneficially Owned Shares or any securities convertible into or exercisable or exchangeable for Ordinary
Shares or other Beneficially Owned Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby represents and warrants
that the undersigned has full power and authority to enter into this Agreement and that this Agreement has been duly authorized (if the
undersigned is not a natural person), executed and delivered by the undersigned and is a valid and binding agreement of the undersigned.
This Agreement and all authority herein conferred are irrevocable and shall survive the death or incapacity of the undersigned (if a natural
person) and shall be binding upon the heirs, personal representatives, successors and assigns of the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned acknowledges and agrees that the
Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any action from the undersigned
with respect to the Offering of Ordinary Shares and the undersigned has consulted their own legal, accounting, financial, regulatory and
tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although the Representatives may
be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection with the Offering, the
Representatives and the other Underwriters are not making a recommendation to you to enter into this Agreement and nothing set forth in
such disclosures is intended to suggest that the Representatives or any Underwriter is making such a recommendation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement shall be governed by and construed
in accordance with the internal laws of the State of New York applicable to agreements made and to be performed in such state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement may be delivered via facsimile,
electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com or
www.echosign.com) or other transmission method and any copy so delivered shall be deemed to have been duly and validly delivered and be
valid and effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If (i) the Company notifies TD Cowen and William
Blair in writing that it does not intend to proceed with the Offering, (ii) the Underwriting Agreement is not executed by June 30, 2025
or (iii) the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated for
any reason prior to payment for and delivery of any Ordinary Shares to be sold thereunder, then this Agreement shall immediately be terminated
and the undersigned shall automatically be released from all of his, her or its obligations under this Agreement. The undersigned acknowledges
and agrees that whether or not any public offering of Ordinary Shares actually occurs depends on a number of factors, including market
conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1.5pt solid">(Name of Stockholder - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1.5pt solid">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1.5pt solid">(Name of Signatory if Stockholder is an entity - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1.5pt solid">(Title of Signatory if Stockholder is an entity - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 39; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ea024708601ex5-1_allot.htm
<DESCRIPTION>OPINION OF GOLDFARB GROSS SELIGMAN & CO
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: right">June 25, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">Allot Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">22 Hanagar Street<BR>
Neve Ne&rsquo;eman Industrial Zone B<BR>
Hod-Hasharon 4501317, Israel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: 0.5in">We have acted as Israeli counsel to Allot
Ltd., an Israeli company (the &ldquo;Company&rdquo;), in connection with a Prospectus Supplement (the &ldquo;Prospectus Supplement&rdquo;)
filed pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), dated June 24, 2025,
to the Registration Statement on Form F-3 (File No. 333-286174) (the &ldquo;Registration Statement&rdquo;) filed by the Company with the
Securities and Exchange Commission under the Securities Act, relating to the offering for sale of an aggregate of 5,750,000 Ordinary Shares,
NIS 0.10 par value per share, of the Company (the &ldquo;Shares&rdquo;), at a purchase price of $8.00 per Share, which includes up to
750,000 Shares subject to an underwriters&rsquo; option to purchase additional shares. The Shares are to be sold pursuant to an underwriting
agreement by and between the Company and TD Securities (USA) LLC and William Blair &amp; Company, L.L.C., as representatives of the several
underwriters named in Schedule A to the Underwriting Agreement, dated June 24, 2025 (the &ldquo;Underwriting Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: 0.5in">This opinion letter is furnished to you
at your request to enable you to fulfill the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.55pt">In connection herewith, we have examined and
relied without investigation as to matters of fact upon (i)&nbsp;the Registration Statement and the exhibits thereto, (ii) the Prospectus
Supplement, (iii) the Underwriting Agreement, and (iv) such certificates and statements of public officials and officers and representatives
of the Company, and originals or copies, certified or otherwise identified to our satisfaction, of such other documents, corporate records,
certificates and instruments, as we have deemed necessary or appropriate to enable us to render the opinions expressed herein. We have
assumed the genuineness of all signatures on all documents examined by us, the legal competence and capacity of natural persons, the authenticity
of documents submitted to us as originals, and the conformity with authentic original documents of all documents submitted to us as copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.55pt">Based upon the foregoing, in reliance thereon
and subject to the assumptions, comments, qualifications, limitations and exceptions stated herein, we are of the opinion that the Shares
have been duly authorized and, when issued and paid for in accordance with the terms and conditions of the Underwriting Agreement, will
be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.55pt">We are members of the Israel Bar and we express
no opinion as to any matter relating to the laws of any jurisdiction other than the laws of Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex5-1_002.jpg" ALT="" STYLE="height: 86px; width: 860px">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><IMG SRC="ex5-1_003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.55pt">We hereby consent to the filing of this opinion
on Form 6-K, the incorporation thereof by reference in the Registration Statement and to the reference to our firm appearing under the
caption &ldquo;Legal Matters&rdquo; in the Prospectus Supplement. This consent is not to be construed as an admission that we are a party
whose consent is required to be filed as part of the Registration Statement under the provisions of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Goldfarb Gross Seligman &amp; Co.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Goldfarb Gross Seligman &amp; Co.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ea024708601ex10-1_allot.htm
<DESCRIPTION>AMENDMENT TO CONVERTIBLE PROMISSORY NOTE, DATED JUNE 24, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>AMENDMENT TO CONVERTIBLE PROMISSORY NOTE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS AMENDMENT TO CONVERTIBLE
PROMISSORY NOTE (this &ldquo;<B><I>Amendment</I></B>&rdquo;) is made as of this June 24, 2025 by and between Allot Ltd., an Israeli company
(the &ldquo;<B><I>Company</I></B>&rdquo;), and Lynrock Lake Master Fund LP, a Cayman Islands Exempted Limited Partnership (&ldquo;<B><I>Lynrock</I></B>&rdquo;
and, together with the Company, the &ldquo;<B><I>Parties</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
and Lynrock entered into a Securities Purchase Agreement (this &ldquo;<B><I>Agreement</I></B>&rdquo;) dated as of February 14, 2022 pursuant
to which the Company issued to Lynrock a convertible promissory note (the &ldquo;<B><I>Note</I></B>&rdquo;) of face value $40.0 million
dated February 17, 2022; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Parties
have entered into this Amendment to the Note in order to facilitate the potential repayment of the Note under the terms and conditions
set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW THEREFORE</B>, in consideration
of the terms, conditions and covenants set forth below, and other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, the parties, intending to be legally bound hereby, promise and agree as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <B>Interpretation.</B>
Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Note. The foregoing recitals
are incorporated by this reference and made a part of this Amendment. Unless otherwise provided herein, all section references herein
are to the corresponding sections in this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <B>Treatment
of the Note upon the Closing of a Qualified Offering.</B> In the event of the closing of a Qualified Offering on or before June 30, 2025,
the following transactions shall be effected:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Repayment
of $31.41 Million of Principal Amount</U>. Concurrent with the closing of a Qualified Offering, the Company shall remit to the Holder
the amount of $31.41 million by wire transfer in immediately available funds in accordance with Article XIV of the Note which payment
is in full and complete satisfaction of the repayment of $31.41 million of the outstanding Principal Amount, leaving $8.59 million of
the Principal Amount outstanding (the &ldquo;<B><I>Balance Amount</I></B>&rdquo;). The Holder hereby agrees to such prepayment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Conversion
of $8.59 Million of Principal Amount</U>. Notwithstanding Article V of the Note, concurrent with the closing of a Qualified Offering,
the Balance Amount shall be converted automatically (the &ldquo;<B><I>Conversion</I></B>&rdquo;) without any action by Lynrock into Ordinary
Shares at a Conversion Rate per $1,000 principal amount equal to $1,164.14 divided by the lower of (x) $9.296 and (y) the price per Ordinary
Share paid by the public in the Qualified Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">For the purpose of this Amendment,
a &ldquo;<B><I>Qualified Offering</I></B>&rdquo; means a firm commitment underwritten public offering raising net proceeds to the Company
from the sale of its Ordinary Shares of at least $30.0 million, after deducting underwriting discounts and commissions, but before deduction
of offering expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">For the avoidance of doubt,
Section 5.1(g) of the Note shall not apply to the Conversion and the Ordinary Shares issuable upon the Conversion shall constitute &ldquo;Conversion
Shares&rdquo; for purposes of the Purchase Agreement and &ldquo;Registrable Securities&rdquo; for purposes of the Registration Rights
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company shall deliver to
the Holder all repayment proceeds and Ordinary Shares due upon conversion in full without making any deductions for tax or other costs
incurred by the Company in connection with the prepayment or conversion of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <B>Termination</B>.
This Amendment shall be null and void if a Qualified Offering has not closed on or prior to June 30, 2025 (the &ldquo;<B><I>Termination
Date</I></B>&rdquo;). The Note shall remain in full force and effect prior to the closing of a Qualified Offering and after the Termination
Date absent a Qualified Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <B>Counterparts,
Email and .pdf.</B> This Amendment (a) may be executed in two or more counterparts, each of which shall constitute an original but all
of which when taken together shall constitute one contract, and (b) may, upon execution, be delivered by facsimile, electronic mail (including
pdf) or as any electronic signature complying with the U.S. federal ESIGN Act of 2000 or the New York Electronic Signature and Records
Act or any other similar state laws based on the Uniform Electronic Transactions Act or other transmission method, and any counterpart
so delivered shall be deemed to have been duly and validly delivered, and electronic signatures or the keeping of records in electronic
form shall be valid and effective for all purposes to the fullest extent permitted by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <B>Further
Assurances.</B> Each Party shall execute and deliver such additional documents and take such further action as may be necessary or desirable
to effectuate the provisions and purposes of this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <B>No
Third Party Beneficiaries</B>. No person other than the Parties are intended to be a beneficiary hereof and no person other than the Parties
shall be authorized to rely upon or enforce the contents of this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <B>Successors
and Assigns.</B> This Amendment shall be binding upon and inure to the benefit of the Parties and each of their respective successors
and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <B>Governing
Law.</B> This Amendment shall be governed by and construed and enforced in accordance with the laws of the State of New York. The terms
of Article XV of the Note are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9. <B>Expenses.
</B>All expenses incurred by the Parties in connection with the negotiation, execution and delivery of this Amendment will be borne solely
and entirely by the Party incurring such expenses; it being however agreed between the Parties that the Company will pay or cause to be
paid the duly documented out-of-pocket fees, disbursements and expenses of Lynrock&rsquo;s outside legal counsel and tax advisor actually
incurred in connection with the Amendment; provided that such fees, disbursements and expenses shall not exceed $75,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Remainder of page intentionally left blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each of
the undersigned has executed this Amendment as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><B>&nbsp;</B></TD>
    <TD COLSPAN="3"><B>COMPANY:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>&nbsp;</B></TD>
    <TD COLSPAN="3"><B>ALLOT LTD.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ Eyal Harari</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 32%">Eyal Harari</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>&nbsp;</B></TD>
    <TD COLSPAN="3"><B>HOLDER:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>&nbsp;</B></TD>
    <TD COLSPAN="3"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>&nbsp;</B></TD>
    <TD COLSPAN="3"><B>LYNROCK LAKE MASTER FUND LP</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">by: Lynrock Lake Partners LLC, its general partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"> /s/ Cynthia L. Paul</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Name: Cynthia L. Paul</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD> Member</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Signature Page to Amendment to Convertible Promissory Note</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ea024708601ex99-1_allot.htm
<DESCRIPTION>ALLOT LAUNCH PRESS RELEASE, DATED JUNE 24, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Allot Announces Launch of Underwritten<BR>
Public Offering of Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hod-HaSharon, Israel, June 24, 2025 </B>&ndash;
Allot Ltd. (Nasdaq: ALLT; TASE: ALLT) (&ldquo;Allot&rdquo; or the &ldquo;Company&rdquo;), a leading global provider of innovative network
intelligence and security solutions for service providers and enterprises worldwide, announced today a proposed public offering of its
ordinary shares. All of the ordinary shares in the proposed public offering will be sold by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects to use the net proceeds of
the public offering to repay $31.41 million of principal outstanding under the senior unsecured convertible promissory note with a face
value of $40.0 million issued by the Company to its largest shareholder, Lynrock Lake Master Fund LP (&ldquo;Lynrock&rdquo;), on February
18, 2022 (as amended, the &ldquo;Lynrock Note&rdquo;), and the balance for general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the offering, Lynrock has agreed
to convert the remaining $8.59 million of principal outstanding under the Lynrock Note into ordinary shares. Lynrock will enter into a
customary lock up agreement with the underwriters with respect to its ordinary shares, including those to be issued upon conversion of
the Lynrock Note, for a period of 75 days following the date of the final prospectus supplement. The Company will have no outstanding
indebtedness for borrowed money following the repayment and conversion of the Lynrock Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company expects to grant the
underwriters of the public offering a 30-day option to purchase from the Company up to an additional 15% of the ordinary shares sold in
the public offering at the public offering price, less underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TD Cowen and William Blair are acting as the joint
book-running managers, and Needham &amp; Company is acting as lead manager, with respect to the public offering of the ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The public offering is being made pursuant to
an effective shelf registration statement on Form F-3 previously filed by the Company with the U.S. Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) and declared effective on April 3, 2025. The public offering of ordinary shares is being made only by means of
a prospectus supplement and accompanying prospectus. Before you invest, you should read the prospectus in that registration statement
and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. Copies of the
prospectus supplement and accompanying prospectus relating to the public offering may be obtained free of charge at the SEC&rsquo;s website
at www.sec.gov. Alternatively, copies of the prospectus supplement and the accompanying prospectus may be obtained from: TD Securities
(USA) LLC, 1 Vanderbilt Avenue, New York, NY 10017, by email at TD.ECM_Prospectus@tdsecurities.com or by telephone at (855) 495-9846;
and William Blair &amp; Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, or by telephone
at (800) 621-0687, or by email at prospectus@williamblair.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or the solicitation of an offer to buy the securities described above, nor shall there be any offer, solicitation or sale of such
securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state or jurisdiction. Any offer, solicitation or sale of such securities will be made in accordance
with the registration requirements of the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>About Allot</U>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Allot Ltd. (Nasdaq: ALLT, TASE: ALLT) is a leading
global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Forward-Looking Statements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains forward-looking statements,
including statements regarding the size and timing of the public offering, the granting of an option by the Company to the underwriters
to purchase additional ordinary shares from the Company, the proposed use of proceeds of the public offering, and the repayment and conversion
of the Lynrock Note. These statements are not historical facts but rather are based on Allot&rsquo;s current expectations and projections
regarding its business, operations and other factors relating thereto. Words such as &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;believe,&rdquo;
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; and other words and terms of similar meaning (including their negative counterparts
or other various or comparable terminology) are used to identify these forward-looking statements. These statements are only predictions
and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual
results may differ materially from those in the forward-looking statements as a result of a number of factors, including those set forth
in the &ldquo;Risk Factors&rdquo; section of the registration statement and the prospectus supplement for the public offering and the
Company&rsquo;s other filings with the SEC. Any such forward-looking statements are made pursuant to the safe harbor provisions of Section
27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and speak only as of the
date of this press release. Allot undertakes no duty to update any forward-looking statements made herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Allot</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Seth Greenberg</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">sgreenberg@allot.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+972 54 9222294</P></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Allot Investor Relations</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ehud Helft / Kenny Green</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Allot@ekgir.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1-212-378-8040</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>ea024708601ex99-2_allot.htm
<DESCRIPTION>ALLOT PRICING PRESS RELEASE, DATED JUNE 24, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Allot Announces Pricing of Underwritten<BR>
Public Offering of Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hod-HaSharon, Israel, June 24, 2025 </B>&ndash;
Allot Ltd. (Nasdaq: ALLT; TASE: ALLT) (&ldquo;Allot&rdquo; or the &ldquo;Company&rdquo;), a leading global provider of innovative network
intelligence and security solutions for service providers and enterprises worldwide, announced today the pricing of a public offering
of 5,000,000 ordinary shares at a price to the public of $8.00 per share. In addition, the Company granted the underwriters of the public
offering a 30-day option to purchase from the Company up to an additional 750,000 ordinary shares at the public offering price, less underwriting
discounts and commissions. All of the ordinary shares in the public offering will be sold by the Company. The offering is expected to
close on June 26, 2025, subject to customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The gross proceeds from the offering, before deducting
underwriting discounts and commissions and estimated offering expenses, are expected to be $40.0 million, assuming no exercise of the
underwriters&rsquo; option. The Company expects to use the net proceeds to repay $31.41 million of principal outstanding under the senior
unsecured convertible promissory note with a face value of $40.0 million issued by the Company to its largest shareholder, Lynrock Lake
Master Fund LP (&ldquo;Lynrock&rdquo;), on February 18, 2022 (as amended, the &ldquo;Lynrock Note&rdquo;), and the balance for general
corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the offering, Lynrock has agreed
to convert the remaining $8.59 million of principal outstanding under the Lynrock Note into 1,249,995 ordinary shares. Lynrock has entered
into a customary lock up agreement with the underwriters with respect to its ordinary shares, including those to be issued upon conversion
of the Lynrock Note, for a period of 75 days following the date of the final prospectus supplement. The Company will have no outstanding
indebtedness for borrowed money following the repayment and conversion of the Lynrock Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TD Cowen and William Blair are acting as the joint
book-running managers, Needham &amp; Company is acting as lead manager and Northland Capital Markets is acting as co-manager, with respect
to the public offering of the ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The public offering is being made pursuant to
an effective shelf registration statement on Form F-3 previously filed by the Company with the U.S. Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) and declared effective on April 3, 2025. A preliminary prospectus supplement relating to the public offering has
also been, and a prospectus supplement relating to the public offering will be, filed with the SEC. The public offering of ordinary shares
is being made only by means of a prospectus supplement and accompanying prospectus. Before you invest, you should read the prospectus
in that registration statement, the preliminary prospectus supplement filed on June 24, 2025, the prospectus supplement once available,
and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. Copies of the
prospectus supplement and accompanying prospectus relating to the public offering may be obtained free of charge at the SEC&rsquo;s website
at www.sec.gov. Alternatively, copies of the prospectus supplement and the accompanying prospectus may be obtained from: TD Securities
(USA) LLC, 1 Vanderbilt Avenue, New York, NY 10017, by email at TD.ECM_Prospectus@tdsecurities.com or by telephone at (855) 495-9846;
and William Blair &amp; Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, or by telephone
at (800) 621-0687, or by email at prospectus@williamblair.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or the solicitation of an offer to buy the securities described above, nor shall there be any offer, solicitation or sale of such
securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state or jurisdiction. Any offer, solicitation or sale of such securities will be made in accordance
with the registration requirements of the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>About Allot</U>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Allot Ltd. (Nasdaq: ALLT, TASE: ALLT) is a leading
global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Forward-Looking Statements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains forward-looking statements,
including statements regarding the size and timing of the public offering, the granting of an option by the Company to the underwriters
to purchase additional ordinary shares from the Company, the proposed use of proceeds of the public offering, and the repayment and conversion
of the Lynrock Note. These statements are not historical facts but rather are based on Allot&rsquo;s current expectations and projections
regarding its business, operations and other factors relating thereto. Words such as &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;believe,&rdquo;
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; and other words and terms of similar meaning (including their negative counterparts
or other various or comparable terminology) are used to identify these forward-looking statements. These statements are only predictions
and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual
results may differ materially from those in the forward-looking statements as a result of a number of factors, including those set forth
in the &ldquo;Risk Factors&rdquo; section of the registration statement and the prospectus supplement for the public offering and the
Company&rsquo;s other filings with the SEC. Any such forward-looking statements are made pursuant to the safe harbor provisions of Section
27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and speak only as of the
date of this press release. Allot undertakes no duty to update any forward-looking statements made herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding: 0.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Allot</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Seth Greenberg</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">sgreenberg@allot.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+972 54 9222294</P></TD>
    <TD STYLE="width: 50%; padding: 0.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Allot Investor Relations</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ehud Helft / Kenny Green</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Allot@ekgir.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1-212-378-8040</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !? &@# 2(  A$! Q$!_\0
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MQ9)JVFV=NIN+YI]#C^U6MO"IEN"\<: NX%?@5\=/VJ_C3^U3^UW\-?A1J?\
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M7XOA+^T7^U%'X \=?M:_$_3OAM<^-_V>?AU<>#M3U;0O L7CB/P79>%;:_\
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M%A;7%O;?V;9/<+>:K>6-C'+<1_F?^S'\'OV(],_90\%_L!_\%$;[]GZ\^/\
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M&_P;\>2(GP'^+O\ P4#_ &,;;XM6MV_EZ%XDU;P)^R-K?C;X.>"/$0<BVO\
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M']K3C)4H1IS=7Y#N/V_?$%CXO\6>$+[X.VR:BVE_"6Z^$%N_BZYTJX^)=_\
M'#Q%8Z-X&A=]8T6UL;/2M)LM2T^^^(&L:7=:K!X6O[^QT6</=W2F/[8_9H^+
M=S\9-&.NZIX:;P=XG\(?$SQ9\+?''AI=3BUNRTOQKX!U2'3M<32-:AB@CU;1
MIS<6]SIU\(8I'BE:*9!+$]<-)^Q9^S_<3>+9[WX:0:G+XST^;2M1DU36]4U!
MM(TV?78/%$ECX,-UJ4A\%6P\26MIKL4?AO\ L\0:I9VEU"4:WB"^\?"#X5^%
M_A/IWAKP5X$\/PZ!X:T[57N8;.*X:ZFN=1U6]^U:CJNIW]U<3WVIZOJEY*;C
M4=3O9IKN[F;S)Y#C*SB*F73A".%PM6E5]K0O.2ER\L90Y[*5:I\2Y8\O+=U%
M*JIQ@XTECF.(X;K4:,,KRO&87%_6<#^^JJHJ2A&K#ZPESXRO=5*?LX.G*GSR
MQ$:N,A6IT)0PD?WNMSB& 8ZQ1#/_  !,C_/XBK-5[<8@BR.1'$.N<81,<_SQ
G_P#6JQ7Z#'X5_AC_ .DQO^-S]IA\$/\ !#;_  0O^/Z!1113*/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "=!AT# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)].*-U #J*;GFC)S0 ZBFEL49(H =13=U&XT .HIN[-.'2@#G?'/_(E:P/\
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M;^=@L<$9<Y]J\P\*>"]9UJWG\3'Q!>Z;<:K(9BD./]7SM'/M01!=6S5U _\
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M5O=.M-2A,-[;0SQ'^&1 PK'M? OAFSN!/!HEFDH.=Q3//XUT=% [L8$P
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M.)8HUC1555& JC %5[O3+*_>![JVCF:!M\189V'U%6Z,CUI  J.:".XA>&9
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M=;&:3(IA<IV&E66EV_D6-K%;Q#^&)<"B_P!*L=5@\F^M(;B/KMD4,!5P&C-
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MJ-TT<X4,0(RW!^E=.3Q65K=I;RZ7>2/!&[^2WS%03TH01M<ET;6++7=-BO\
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M%-A(0%E49R:QA\6?"6W_ (_G_P"_+?X5>\6>%(O%'AV'3K26*WA69)E*KE<
MYP/K6O/:Z=86#S36UNL<,>YFV#H!0"Y3+T/QYH'B+4C8:==&6X"%RI0C 'U^
MM7]<\3Z1X=B1]3O(X=_W%)RS?0=ZXWX;67VVXU;QA/"(S?2LMJH&-L"\#\ZC
M\$Z=!XIU[6?$VJ1K<NER;:T20;EB5>N >YH&TKW.LT/QSH'B&X-O87RM./\
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MH<<+B6R0,SGH<^E4_#7BV75+^?2-4LS8ZM N]H<Y5U_O*>XK$\,_\E=\3_\
M7)/YT6*43T0_0UB6_B6"X\777A]8G$]O;K.SGH03CBMWM7G>E_\ );M7_P"P
M;'_Z%0D2E>YZ&/>J&KZWIVA69NM1NH[>(=W.,_2KYZ5YE9VL7C'XG:H^H(L]
MEHQ\F&!^5\SN2*!I=3H])^(OAK6;Q;2VU!1.W"K*"F[Z9ZUK:[K^G^';$7NI
M2F*$L$#!2W)[<5D^,/"NG:OX?N4%K%'<0QF2"5%"M&P&001]*9X"U/\ X23P
M593WRI--'F*3>,@LO&?RH&TK715_X6SX2_Y_W_[]-_A70Z!XDTWQ+9-=Z9,9
MH5;86VD<UQ7CO5K5]0@\*:;]E@O;SB:X8 >1'W(_VL=*[;P]HUCH&BV]AIZJ
M((U&"/XO?- -)*YK"FLRH"68 #DD]A3A7G_Q.U&Y\C2M M)6B?5[M8974X/E
M8^?G\J2)2N:%]\3?"MC<M;OJ(D=3AO)4N!]<5OZ-KFGZ_8B\TVX6> G&Y>Q]
M*YNRO_!/AR*/2TN;")D^4@X))]S6Y<7=AI?AVZU"Q6$6Z1-*#"!@G'7BG8II
M;%?7O&N@^'95AU"^1)F&1$OS/CZ#FIM#\5Z-XC5CIE[',R#YX^C+]17*_#30
MK>ZT4>)-1B6XU34F:5YI1N*+DA5&>@P/UJK\0K"'PQ>Z9XKTN-+>>&Z2*Z\L
M;1+&QP0<=:+#LMCI];\?>'_#^HFQU"[,=P%#%0A/!^E9Y^+/A+'_ !_OTS_J
MF_PJW%X42Y\;'Q/++')%):K$(&3.#CKFL_XCW-OI7AX6EG;0B^U!Q;P!4&>>
MIH!<NQU6A:[8>(M-6_TV4RVY8J&QCD5J5B>%=$B\.^&[+3(E"^3&-V.['DFM
MJD0P+ =ZRE\0:?)KSZ-'-OO43>Z*,[!VR>U9?C+Q.=!LTMK)/.U6[/EVT(ZE
MCW/M4'A?2+/PI!&FH7<;ZSJ3&2>5V^:5^I ]ATH';2YV XJ&YN8;2"2>>18X
MHU+.S'  '4U)D8KSG6KF;QWK[>'[&1DT>V8'4)T./,_Z9@T"BCN-%UBSUVP6
M^L69X&)"L5(W8[BM ]*S])FTT0M8Z;)%LLSY+1Q_\LR/X35?Q)K]KX=T>2^N
M3DCY8HQUD<] * MK8=?^(-.T_4[33IYO]+NR1%$HW,<#).!V]ZU0>*X'PS8C
M3WE\5^)YDCU&^(2,2'B!#T1?0GC-=Z"& (/!YS3!Z"E@H))P!69I6OZ?K,]U
M%82^=]F?9(P4[=WH#T-<QXOUR[O]03PKH;G[=.,W,RG_ %$9Z\^M;OAZUTC0
MH(] L98Q- F]X\_.V>K'US0.VAOT444B0HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG]-\46
MVI^)=0T6.WG2:R4,\CKA&SCH?QKH#R#7):!XEGU3Q=KVDR01)'IYC".N=SY'
M>F-'649KS6Y^(NJ#Q9J?A^QTE;NZA;$ 4D<=RQ]*?<>,_%/AV:&;Q-HMJFGR
M.%:XM)"?+)]<]J+#<&=]?7L&GV<UW<N$@B4N['H *Y/1O'PUB^ABAT'5%M+A
MB([QHOW9'KGTJA\4[O6#X.N'TV*VDTZ2'=/*[$. 2,;14G@BZ\41Z98?VC::
M=#I"6X(DC<^8!C(R,XHL4HZ7._%+FO/$\9>(M?GE/A;1X);&-BGVN[<J)"/[
MN*O:%XSO)-:&A>(M/73]292T11B8I0.ZDT6)<6=H64+DD8'>N8U'Q_X;TV=H
M9-0665<AD@!D(^N*S/$5Q=>(_$J>%K*9X+2*/S]1EC.&*GA4!]^2?I5*/7(=
M+NY-&\&^'5O7M?EGE7"1@^A;N:+#4>YT.G?$#PWJ4Z0QZ@D<KG"I,#&2?;-=
M.&! (((/>O)O$WB^$V*V7B3PP$O)9%18Y>5<$X)5O45T'AV>Y\/>(W\,W4[W
M%I+%]HT^60Y94S@QD^W;V-%@<-+H[G-&?>N'UGQK?'7)-"\-Z:-0OXE#3N[8
MCASTR:S=3\;>*?#6GS7.O:);B+8?+FM7+*&QQN![9HL)0;/2LCO2Y%<YHGB1
M;WP;;:_?[(%> 32;>@XYQ7.0>+O%^OHUYH&A6PT[/[J2\D*M*/4>U%@46>B$
M\^U8-IXGM[OQ;>^'UAD$]K$LK2'&"#6?X9\82:KJ,VCZK9_8-7A7>T).5=?5
M3WK&T3GXU>(/>QCS^8HL/E/1Q5#6]5CT31;K4ID9X[=-[*O4BN7UKQI?'7)-
M#\.:<M_?Q &=Y&Q%%[$^M<[XO\2^(;/PMJ-IXETB&&.YB*17-FY9=W8-GIWH
ML"@[GHNG:S;ZAH4.L;3%!)#YIW_PK[USNF_$1-6OH4M-"U.2RFD\M+T1?NSS
MC/T]ZP+Z;6H?@]9_V7#;R0G3V^TM*Q#!<'[M6OAW<>*UT324>QL/[(\D8<.?
M,VX]*=BN16;/3,\4N:X!O$'C?4)Y7TOP]:PVZ.55KR0AVQW^E7_"GB^XUF_N
M](U6R%EJUIAGB!RK*?XE-*Q'*[7.OR*R]?UF+P_HMWJLT;21VZ%V5>IKD?$?
MQ O-#\8KH4&G"\:6WW0HF0S.>V>F*A\4W>O77PQUV77;.WM)?).Q(7+?+[^]
M%@46=[I=^FJ:5:7\:E4N84E53U 89_K5SBO+/#WB7Q+J7A[3H?#FCP/;6]M'
M$UQ>,4#LJ@':!VSD9K>T#QG=3ZW_ &%X@T]=/U0J6C"MF.8#KM-%AN#1VF12
MY%1LZHA9B  ,DGL*X$^-==UV\FC\)Z3#<VD+E&N[IRJ,PZ[<=:1*39Z%FDR*
MY#P_XDUJXU9]*U_2/LERJ>8DT)+1..G7UJC>>-=6U/59].\*Z7%>&V.V:ZN&
M*QJWH,=33L/E9WN<=Z,^]<%9>--6T[5[?3?%>F0V?VEML-S Q:)F[ YZ5+XZ
M\;R^$KW2$2V$\%Y(RR 9W  #&W'UHL'([V.XHKSFX\3>.X+5M2_X1RS%BHWM
M%YI\[9ZX]<4EM\1-2\2(J>$](6XD509WNF*I$W]W/<T6#D9Z/FE'2N"T?QEJ
ML/B&'0O$VG16=S< FWEA<F.3V^M=X.E(3BUN<]XY_P"1*UG_ *])/_037G_@
M^T^(+^$M,;3;_24LC OE)-&Q8+CC)S7J>M::NL:/=Z<\AC6XB:,NHR5R,9J+
M0-'30="L],CD:1+:,1AV&"<4[E*5HV/,O#UI?ZYXZEM_&5]YM]IA$EI:(@6)
MP?XQW-:M\R6GQQLI;W"Q3:<8K5FZ>9GD#\*ZC7_"L.LZC8:E%.UI?6;Y29%S
MN7NI]JF\0^%M/\3V207P99(SNBGC.V2-O4&@?,:MQ-%%:R23,$C5"69CP![U
MY-X.BDD^&/B.2"-A:3S3O:K_ +&>WZUOGX;7=VHM]4\4:A>6(Q_H^ FX#L2#
MS7;6NG6EEI\=A;PHEJB;!&!QB@5TCG?AI+'+\/M(V,&VQ;3CL03D5S^K7<,W
MQST."-@SQ6LH?!^[E3_A5U_AK+974S:'X@O=-MIG+/ @#*">NWTJSIGPXL=)
M\1V6MQ7MQ-<VZ.)&F^8RLPQDGMCTHN4G'FN9WB&))OC5X<$B@A;25A]1G%=]
MJ0SIEWGG,+\?@:R+WPS%>>,+#Q$UPZR6D+1"(#@@UN7$(N+>6$G'F(5./<8H
M(;V/,/!*33?!K48X,F4_:50"NB^%\UM)X#T]("-\:[)E[A\\YK5\+^'(?#.B
M?V;',TR;W?<P_O=JPKWX=*NH2WFA:Q=:2\QS+'%AHV/J!VHN-M.Z,;XOW%IY
M_A^W)4W9O591W"YKU):\\E^%-G<F&XN]4NKF_CG65KF;DG'\('85Z&O6AA)K
ME20X]*\Z\"_\CUXO_P"OH5Z*>E<_HOAB+1M:U744N'D;4) [*PP$-"$G9'+2
MLMM\<%>\(436 6V9NF>X'XUW]_/!!87$MR0L"H3(6Z8QS65XE\+6'B6VC2[\
MR*:([HIXCM>,^QKG/^%;W=YMAU;Q/?WEB#G[/@)OQV8CK0.Z=KF3X)T5M=^&
M.L6,BX@N[B<VN?X1U4C\<53EUR?Q)X/T;PVKD7]S<"UNQGE40_,?TKUNRLX+
M"TBM;:-8H8U"HH'05S>F^!-/TSQA>>(HW=I9\[8L?+&3U(^M%Q\RNS%U**+P
M=\0;"_C BTW4+;[+-Z*Z#Y3^5-\+6\^L)XF\3@$RW^^WM/:-%*C'U8G\JZGQ
M7X7M?%>B-IT\KQ?,&61/O*16AHVE0:+HUKIMO_JK= @)ZGWHN',FCRGX>V'B
MFZ\.%-*\16=K'%.Z20/9;G1L\Y.[FMRZ\&^)]3U32YM5\2VDALYQ,BQV>QCC
MKSNK5U7X?17&I2:CH^IW6DW<G^L,&"CGW6I]"\$_V;J:ZGJ&KWFI7JJ55I3M
M1?HHHN.4EN86J0I+\=-(\P [=-9@#V(<\_K7I)8*,L0 .I-8,_AB*?QK;>(S
M<,)(;8VXBQP03G-9GQ/ADN/!%U'!+/'<-)&(O))W,Q<#MVYS^%!+]YG9=1Q5
M+5_^0/>?]<7_ )&ETF"2VTFT@D<N\<2AF/4G%3W=N+JTE@)P)%*D^F10B5HS
MB_A!_P DYT_ZO_Z$:[*\N8K*TFN9V"Q1(79CV %9GA7P_'X7T"#2HIFF2$MA
MV&"<DG^M.\3:&WB/0Y]+^UO;)/@2.@R2H.<?C1U&][GE_AC4?%,NK:CXFM?#
M0OO[0;$4KW 3;&.B@8H\77OBR6ZL->G\-_8FTN3S'G2<.3'W7'>O8+"Q@TZP
M@L[=0L4*!%'L*==VD5[:RVTH!CE0HP]C05SJYG'Q%8)X;37))E6S:$2[O8CH
M/?M7*^%M-N?$NM'Q;K,95%RNG6S\B)/[Y]S27?PP^T>&K;0EUNX2UMIVE0;,
M\'D*>>@.?SJ6/P'K<4:QQ^,KU448 $"C'ZT: N6Q5^,*K)H&G(PRK7T8(_$5
MZ&BJEN%0855P![5S.L>#AK6B6.GWFH2N]K*LIG*C,A'J*Z@+\NW)Z4$MJR/.
M/AB&-EXI"?>.IS ?7%<_X"L/%$]A?0Z7K]K9-%=R>;;RVGF."3U)W"O2O#'A
MB'PTFH"*X:;[9=-<,6&-I/:LW6O ,%_J;:IIFH7&E7[#YY+?E7_WE[T7*4D8
MNJ>"_%6LO9IJGBBS=(9A+&$LMK9'/!W5)XF!_P"%L^%AGD029/KS6KHW@1[/
M4XM2U36KS4KF'_5!SM1/P'6M/4O"\6H^*=-UQKAT>Q1D6,#ALT7#F1ROB?\
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MRQ[D^]9R^%8CXR?Q%/</-*(A%#$1\L8]12%=7N:MEIL.G:/!IML-L4,(B7Z
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M3LH+QAL[3Z9JU112,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,?K4WB'P+:ZSJ"ZG:WD^G:D!C[1;G[P_VAWK)G^%ZZG;3+K6N7FHS,A2)I
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M+44L\<"[I9%1>F6.!0!(% &,48'I0#D4M !BC HHH 3 ]*1D1QAE!'N*=10
M8%&*** $P*7 HHH *,444 &*3 I:* # I"!BEI#0 8'I1@>E(6 /)HSD<4 .
MI*3/'6DWB@!^**3-*.E "8HQ2$XH#=CQ0 N*,"DSSUH+8ZT +@48IH;)IQ.*
M "@C--+8-+GTZ4 +BCBDW8&3Q0&R.* LQ<444A;!QF@08!&,4(BH,*H4>@%&
MX?WA2@Y]Z!BT8%%% !@4F!Z4M(3@$GM0 N*,"HHY5E7<CJR^H.14M "8HQ1F
MHXYXY6*HZL5.#M.<?6@5B3 QTHVCTI110,3 QC%&T>E+10 8%)@>E+10 UHT
M8@LH)!R,CI3L444 )@>E+@444 &*,444 &*,444 %&!110 F!G.*,#TI:* #
M HHHH 3 I<"BB@!I1"P8J"PZ''2E  Z"EHH ,4F!2T4 )@>E+@444 )@>E+B
MBB@!,#TI<"BB@!,#THP/2EHH 3'I5./2K"+5)=22UC%[*@C>;'S%1VS5VB@
MHQ110 8%)@>E+10 F!Z4N!110 4444 )@>E+@444 )@>E+BBB@ HHHH ****
M "C HHH *,444 &**** "DP*6B@ I,"EHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
-44 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex5-1_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !  &L# 2(  A$! Q$!_\0
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?D<9!I<OM?9\L,8I.+G45/$QO*K72_1NBBBN<\0__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
